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Abstract
Accurate medication adherence and the self-efficacy to properly adhere are essential for
breast cancer survivors. Not only are these patients often continuing their treatment with
adjuvant therapies, they are frequently taking medications for other medical, or comorbid, issues
such as diabetes, asthma, high blood pressure, arthritis, and congestive heart failure. With the
increasing number of breast cancer survivors (ACS, 2009), there is a growing need for empirical
research of their medication usage and the influence that health literacy has on proper adherence.
Inadequate medication adherence, lack of perceived self-efficacy in proper adherence,
and low health literacy are factors that have received minimal attention with respect to breast
cancer survivors, particularly those who are underserved with comorbid health issues. It would
be beneficial to address these issues within a collaborative framework that addresses the multiple
factors affecting them. The merits of the collaborative model of healthcare are in stark contrast to
the medical model, indicating the need to use the former with breast cancer survivors.
An underlying assumption of this dissertation is that traditional medical treatment of
breast cancer is the preferred and primary course of action chosen by breast cancer patients. This
course is not globally accepted, and even those choosing a traditional medical route are adding
complementary and alternative medicine to their treatment (Boon et al, 2000; Lee, Lin, Wrensch,
Adler, & Eisenberg, 2000; Richardson, Sanders, Palmer, Greisinger, & Singletary, 2000). For
the purposes of this paper, however, it is assumed that the majority of those diagnosed with
breast cancer choose traditional medical courses of treatment.
This dissertation reports the exploration of the impact of a skills development
intervention on medication adherence and self-efficacy. Chapter 1 provides a statement of the
problem that was examined, the purpose of the study, and the objectives of the research.
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Chapters 2 through 5 present a review of the literature that relates to the multiple components of
the study’s framework. Chapter 6 contains methodology, chapter 7 reports the results chapter 8
provides discussion of the findings, and Chapter 9 offers the conclusion and personal thoughts of
the researcher.
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Chapter 1
Statement of the Problem
Louise is a 58-year-old African American woman who was diagnosed with breast
cancer four years ago. Upon diagnosis, she had a lumpectomy, chemotherapy, and radiation. She
is in her third year of taking the oral medication tamoxifen. In addition, she takes eight
medications for comorbid conditions, or other health issues, which include diabetes,
hypertension, and asthma. Louise has four children and is the primary caretaker of her two
grandchildren. She is insured through Tenncare, the state healthcare coverage, which pays for
only five of her medications. Although her children are able to help her when they are not
working, she often does not have transportation to doctor appointments and the pharmacy. She
receives diabetes counseling at the clinic where she is treated, but has difficulty understanding
her rigid schedule of blood glucose monitoring and insulin injections. She also experiences flulike symptoms that could be due to tamoxifen. In addition to her physician, the oncology clinic
has a nurse practitioner and social worker on staff to monitor progress with her breast cancer
survival, but Louise does not want to “bother them” with questions about treatment and coping.
Her retail pharmacist explained her medications to her when she first had them filled, but she
cannot remember the oral instructions and has difficulty reading the prescription labels and
patient leaflets. Louise reports having her medications in a pill box partitioned by days of the
week but comments that she only takes her oral medications when she is feeling run down in
order to make them last longer.
Louise’s story reflects many of the barriers that breast cancer survivors face in
achieving optimal health and quality of life after breast cancer treatment. Her story also
emphasizes the need for a healthcare approach that addresses the biopsychosocial issues of the
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patient, among them health literacy, medication adherence, and self-efficacy. The purpose of this
study is to 1) provide an empirical foundation for examining the link between medication
adherence, self-efficacy and health literacy within a collaborative model of health care, 2)
examine the psychosocial barriers to proper medication adherence, 3) provide evidence that
research on these issues is lacking among underserved breast cancer survivors and 4) provide
results of a study that will evaluate hypotheses that have been formulated to address these issues.
Former United States Surgeon General C. Everett Koop once said, “Drugs don’t work in
patients who don’t take them” (Osterberg & Blaschke, 2005). This simplistic yet accurate
statement summarizes the dilemma faced by healthcare providers and patients in the quest for
optimum health care. Such is the case for all patients, but perhaps none more so than the growing
population of female breast cancer survivors (ACS, 2009), particularly those who are
underserved. As illustrated by the case above, there are numerous factors that need to be
addressed when examining the lack of proper medication usage with this particular group of
women.
Women who have survived breast cancer are valiant warriors of a disease that strives to
rob them of their lives, hope, and dignity. As if that is not enough, there are untold numbers of
women who have to face the added burden of navigating the complex systems that are designed
to help them. These psychosocial aspects of survival can be extremely challenging for women
who are underserved. Survival for many women means adding another disease state to those that
they are already dealing with. Comorbid issues are not only more challenging to treat for
survivors but can impede chances of optimum survival. In a cohort study of 906 breast cancer
patients, Tammemagi and colleagues found a total of 77 comorbid health issues associated with
decreased survival. In addition, at least one comorbidity was found in 86.0% of the African-
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American patients (n=221) and 64.7% (n=407) of the white patients (Tammemagi, Nerenz;
Neslund-Dudas; Feldkamp & Nathanson, 2005).
Coping with multiple diseases compounds the psychosocial issues that survivors face
with respect to medication. For example, Louise is faced with the hardship of inadequate
resources for acquiring her medication, such as transportation to pick up medications and attend
appointments to obtain prescriptions. She also faces the burden of juggling the Tenncare
restriction of five prescriptions when filling her eight medications. Prescription costs are an
added stress to her situation. In addition to costs are the multiple drug regimens she must follow
on a daily basis. Checking blood sugar and blood pressure and maintaining proper asthma
control are difficult problems without the added onus of breast cancer survival. For patients like
Louise, the cognitive and psychological burdens of breast cancer treatment can impede the
medical outcome. The patient is often presented with an overwhelming amount of information
about treatment that he or she is unable to comprehend.
The inability to properly understand health information produces a formidable barrier to
receiving optimum health care (Jeppesen, Coyle & Misser, 2009). Wallace (2006) asserts that
health literacy needs to be a key demographic variable studied in empirical research. The
rationale for investigating the link between health literacy and medication adherence is the
importance of patient understanding when taking medication. Health literacy is a component of
the cognitive and functional skills needed for adequate medication adherence (Ngoh 2009), and
patients with inadequate health literacy are more likely to take medications incorrectly (Georges,
Bolton & Bennett, 2004). Although empirical inroads have been made in the evaluation and
measurement of health literacy, more research needs to be done in order to ascertain the ability
of patients to receive and process health information (Chew, Bradley, & Boyko, 2004).
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It is necessary to address medication adherence, self-efficacy, and health literacy with
the main focus on the patient. For patients like Louise, resources are available to provide
education, information and means to cope with her survival issues. However, she is not able to
utilize these resources for several reasons. First, she is faced with transportation issues due to
lack of physical support from family and friends. This may be due to unwillingness to ask for
help or a lack of knowledge of available resources. Second, Louise’s lack of understanding about
her treatments and medication could be improved if she took advantage of the resources that she
is already aware of. She lacks the confidence to speak up for herself and ask for help. She may
also be intimidated by the overwhelming amount of information that is presented to her in a
manner that she cannot understand. Further, she may be at the mercy of a system that functions
within a model of healthcare that does not consider the person in the environment.
It is insufficient to only examine the link between medication adherence, self-efficacy,
and health literacy. This methodology is reflective of a medical model of health care, which is
not an inclusive approach (Fang, Machtinger, Wang & Schillinger, 2006). Lindau and colleagues
find that the resistance to a transition from the medical model to a more collaborative approach is
twofold: 1) medical and research scientists and healthcare providers continue to utilize a linear
progressive approach of disease from etiology to health outcome, and 2) research continues to do
the same (Lindau, Laumann, Levinson & Waite, 2003). The link between health literacy and
medication adherence needs to be examined within an integrative, biopsychosocial structure, and
research pertaining to these issues needs to reflect this approach.
The medical model of healthcare does not incorporate considerations of the psychosocial
aspects of treatment (Andrist, 1997; Bird & Reiker, 1999). This deficiency is important when
considering the behavioral aspects of patients and the collective, relational, social systems in
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which they live. Furthermore, the use of the medical model challenges the social work code of
ethics concerning social justice (Thyer, Sowers & Dulmas, 2008). A biopsychosocial approach to
health care encompasses the whole person, thereby recognizing strengths and limitations as well
as the social and environmental aspects of the patient’s life.
It is the position of this paper that collaboration and consideration of psychosocial issues
must include recognition of where the individual is with respect to beliefs regarding health and
the individual’s self-efficacy to cope. This is a critical component when considering a patient’s
identification of the need to change behavior, such as adherence to medication, and the
willingness and ability to do it. Empowerment of an individual to self-determine benefits and
risks of action or behavior are crucial to change.
Merely recognizing that a problem exists and having the research to support it may be
noble and noteworthy, but the problem will remain unless corrective action is taken. Exploring
the issue of inadequate medication adherence and low health literacy among underserved breast
cancer survivors will not improve these issues until research ascertains the impact of intervention
on them. From the perspective of this study, there are three presenting problems that need to be
addressed. First, there is a gap in research regarding medication adherence, self-efficacy in
proper medication adherence, and health literacy among underserved breast cancer survivors.
Second, this population is at risk for inadequate self-efficacy for coping, lower health literacy,
and improper medication adherence. Gaining access to services and support throughout
treatment, recovery, and survival is crucial in improving quality of life for breast cancer patients
and their family systems (Freeman, 2006; Hiatt, et al., 2001; Till, 2003). There is little if any
research regarding these issues with respect to the impact that the psychosocial environment has
on self-efficacy. Third, these gaps in research include the lack of use of interventions
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implemented with the purpose to improve medication adherence and health literacy in this
population.
Purpose of the Study
The purpose of the study is to contribute to the body of knowledge addressing
medication adherence, self-efficacy, and health literacy among African American breast cancer
survivors. The following questions were posed for this study:
1. What is the level of medication adherence among breast cancer survivors?
2.

What is the level of self-efficacy in taking medications among African American breast
cancer survivors?

3. What is the level of and role of health literacy in medication adherence among African
American breast cancer survivors?
4. What impact would skills intervention have on medication adherence, health literacy, and
self-efficacy among African American breast cancer survivors?
Objectives
There are three primary objectives and two secondary objectives of the study.
Primary Objectives:
Objective 1: To evaluate the efficacy of a medication adherence skills intervention alone
compared to a medication adherence skills intervention in conjunction with a cancer skills
psychoeducational program in increasing medication adherence for African American breast
cancer survivors.
Objective 2: To evaluate the efficacy of a medication adherence skills intervention alone
compared to a medication adherence skills intervention in conjunction with a cancer skills
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psychoeducational program in increasing self-efficacy in medication adherence for African
American breast cancer survivors.
Secondary Objectives:
Objective 1: To conduct analyses to determine the role of health literacy in medication
adherence and self-efficacy.
Objective 2: To collect data for future analysis to be conducted on the psychosocial
factors (e.g. depression, quality of life) impacting medication adherence.

7

Chapter 2
Overview of Breast Cancer
Br east Cancer Facts and Figur es

Breast cancer is an insidious disease that affects not only those diagnosed but the people
who are closely connected to them (Davis, 2009). New cases of diagnosed breast cancer are
increasing at an alarming rate. Based on breast cancer incidence rates reported to the North
American Association of Central Cancer Registries (NAACCR, 2009), 192,370 new cases of
invasive breast cancer and 62,280 new cases of in situ breast cancer in women in the United
States were projected for 2009 (ACS, 2009; Copeland et al., 2009). Even so, breast cancer is no
longer a death sentence. Early detection and improvements in treatment have resulted in
increased survival rates. According to collected U.S. cancer incidence data by the National
Cancer Institute, approximately 2.4 million women with a history of breast cancer were alive in
January 2006, and most were determined to be cancer free (ACS, 2007; Horner et al., 2009). As
a result, the population of breast cancer survivors is growing into a body of women with distinct
strengths, limitations, and issues that need to be addressed. The following section will look at the
survival phase of breast cancer. Because breast cancer in men accounts for 1% of cases in the
United States, it is considered rare among males (ACS, 2009). For the purpose of this
dissertation, references to breast cancer and breast cancer survival will apply to women.
Survival Phase of Breast Cancer
The term survivor carries many meanings and can refer to a patient who is recently
diagnosed with cancer or one who is in the post treatment phase. Mullan (1985) conceptualized
cancer as three seasons of experience: diagnosis and treatment (acute stage), remission (extended
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stage), and permanent or end-of-life stage (Mullan, 1985). The Centers for Disease Control
(CDC, 2009) consider survivorship to mean the time of diagnosis through remaining years of life
(DHHS, 2009). The American Cancer Society (2009) asserts that each individual patient has the
right to his or her personal definition of survivorship. For the purposes of this paper, use of the
term survivor will be in accordance to the definition of the CDC to include all patients who have
received a diagnosis of cancer.
The survival phase of breast cancer is receiving increased attention in the literature as
well as the media (Abel & Subramanian, 2008; Davis, 2009; Mayer, 2003). Earlier detection and
use of adjuvant therapy have been instrumental in increasing survival rates, but have also created
a phase of cancer in which the needs of the patient are often neglected. Accordingly,
psychosocial care and treatment in the post treatment phase of survival need increased attention.
The conveyor belt of care that begins with a diagnosis of breast cancer and continues through
treatment often ends abruptly with the last chemotherapy or the final radiation visit or the fiveyear checkup where the patient is sent on her way cancer free. A longitudinal study of 558
treated breast cancer patients illuminated the fact that although treatments have become more
sophisticated and patient friendly, quality of care often diminishes or disappears once
chemotherapy and radiation end (Ganz, et al., 2004). This dilemma is compounded by the
existing identifiable factors that affect breast cancer survival.
Factors affecting breast cancer survival. The American Cancer Society reports the
most recent relative survival rates for women diagnosed with breast cancer as: 89% at five years
after diagnosis, 82% ten years after diagnosis, and 77% fifteen years after diagnosis (ACS,
20011). There are several factors that influence the survival rate of breast cancer. Among these
are 1) stage at diagnosis, 2) age, 3)race/ethnicity, and 4) socioeconomic factors (ACS, 20011).
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These factors will be discussed below and followed by an examination of underserved breast
cancer survivors.
Stage at diagnosis. Women diagnosed at a more advanced stage and women with larger
tumor size have lower five-year survival rates (ACS, 20011). When all races are considered, the
five-year relative survival rate is 98% for localized tumors, 84% for regionalized cancer, and
23% for distant stage disease (Horner, et al., 2008). When controlling for race in women with
regionalized disease, the 5-year relative survival rate is 95% for tumors less than or equal to 2.0
centimeters, 82% for tumors 2.1-5.0 centimeters, and 66% for tumors greater than 5.0
centimeters (Horner et al., 2008).
Age. Women who receive a diagnosis of breast cancer before the age of 40 have an 83%
5-year survival rate, and women diagnosed at age 40 or older have a 90% 5-year survival rate.
Tumors diagnosed at younger ages tend to be more aggressive and less responsive to treatment
(Anders et al., 2008; Goldhirsch et al., 2001). In 2006, 250,000 women in the United States
under the age of 40 were living with a diagnosis of breast cancer (ACS, 2007; Davis, 2009).
Race/ethnicity. African American women have a 78% 5-year survival rate compared to
white women who have a 90% survival rate (Horner et al., 2008). The discrepancy has been
attributed to delay in detection, which results in more advanced stages of breast cancer at
diagnosis (ACS, 2009). Aggressive tumor characteristics with poorer prognosis are more
common in African American women (Carey et al., 2006; Morris & Carey, 2007). African
American women have the lowest cause-specific survival rate, which is the probability of not
dying of breast cancer within 5 years of diagnosis, of any ethnic or racial group. This indicates
that African American women have the highest probability of dying of breast cancer (ACS,
2009; Horner et al., 2008). In 2007, death rates among African American women were 41%
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higher than white women even though death rates for African American women had declined
1.6% annually between 1998 and 2007 (ACS, 2011). A recent study by Christiansen and
associates (2012) reported that African American patients with nonmetastatic triple negative
breast cancer had significantly lower 5-year disease free survival and significantly higher 5-year
recurrence rate (Christiansen et al., 2012) Additionally, while investigating risk factors for
disparities in breast cancer mortality among African American and Hispanic women in Texas,
Tian and associates discovered that patients in the studied population with higher poverty status
were more likely to exhibit significant racial disparities in breast cancer mortality for both racial
groups (Tien et al., 2012).
Underserved breast cancer survivors. Lower survival rates of breast cancer are
associated with lack of health insurance (Halpern, Bian, Ward, Schrag, & Chen, 2007) and lower
income (Singh, Miller, Hankdy, & Edwards, 2003). Comorbidity, inequality of access to care,
and treatment disparities between lower and higher income patients and African American and
white women affect the survival rates of underserved breast cancer survivors (Baquet, Mishra,
Commiskey, Ellison, & DeShields, 2008; Curtis, Quale, Haggstrom & Smith-Bindman, 2008;
Newman et al., 2006; Tammemagi et al., 2005; Smedley, Stith & Nelson, 2003).
Longitudinal analysis of hospital discharge data reveals that minority women insured by
Medicaid are undertreated for breast cancer (Ayanian, Kohler, Abe & Epstein, 1993). Some
researchers assert that, regardless of insurance status, medically underserved patients are less
likely to receive quality medical services throughout the continuum of cancer care (Kressin,
2005; Smedley et al., 2003). In contrast, federal screening programs report findings through the
National Breast and Cervical Cancer Early Detection Program that low-income women received
similar standards of care comparable to that of all women studied (Liu et al., 2005). This

11

discrepancy in results might be attributed to the type of methods used by the studies as well as
the source of the data. The former studies deals with care post diagnosis and the latter study
focuses on early detection and screening.
Adjusting to survival. Adjustment to living with a diagnosis of cancer has been
described as being burdensome and lengthy, with deterioration of quality of life affecting
biological processes and health outcomes (Alfano & Rowland, 2006; Anderson, Kiecolt-Glaser,
& Glaser, 1994). Health related quality of life is an important component of the survival phase of
breast cancer patients. Surveying nearly one thousand breast cancer survivors allowed Engel and
colleagues (2003) to report that demographic and clinical factors, such as comorbid conditions,
body image, education, and physical difficulties, affect quality of life (Engel, et al., 2003).
Exploratory studies employing patient interviews reveal that post treatment transition into
survivorship can result in decreased physical functioning (Dow, Ferrell, Leigh, Ly &
Gulasekaram; 1996; Ganz, et al., 2004; Schag, et al., 1993), mood disturbances, psychosocial
problems, and poorer quality of life (Cappiello, Cunningham, Knobf, & Erdos, 2007; Dow et al.,
1996 Schag, et al., 1993; Shimozuma, Ganz, Petersen, & Hirji, 1999).
Multiple interrelated factors can minimize the ability of survivors to lead full and
complete lives. Treatment of breast cancer survivors needs to be provided in a manner that will
address the biopsychosocial needs of the patients. Such treatment is difficult if not impossible
within the medical model of healthcare. The following section will support the premise that
collaborative care is the most effective framework of treatment for breast cancer survivors.
Medical Model vs. Collaborative Model in treatment of Breast Cancer Survivors
This paper assumes that use of the medical model of healthcare does not adequately
address the psychosocial needs of patients (Andrist, 1997; Bird & Reiker, 1999). In this section,

12

the medical model will be contrasted with the collaborative approach. This will provide evidence
that use of the collaborative model in breast cancer treatment provides a biopsychosocial structure
in which to address health literacy and medication adherence among breast cancer survivors. First,
the medical model will be defined and examined with respect to its limitations in the treatment of
breast cancer survivors. This will be followed by an examination of collaborative care, as the
goodness of fit of this model for treating breast cancer survivors, particularly when addressing
medication adherence and health literacy.
Medical Model
Definition and overview. The paradigm of practice known as the medical model has been
the gold standard of healthcare for centuries with little historical competition or empirical
challenges until recent decades. The medical model of healthcare has been described as an
individualistic concept of healthcare (Engel, 1977; Weick, 1983), progressing from a recognition
of symptoms and characterization of etiology to rational, specific treatment (Engel, 1977). It is a
method of service delivery and medical care that focuses on the biological causes of disease
(Gehlert & Browne, 2006).
Analyses of gender specific treatment and healthcare inequality resulted in the assertion
that the approach of the medical model treats the biological issues of the patient but does not
address the psychosocial needs. (Bird & Reiker, 1999; Calnan & Johnson, 1985). This neglect of
the whole person and the environment in which the person lives limits the ability of the medical
model to be an effective framework in which to treat patients, particularly breast cancer
survivors.
For example, as illustrated in the introduction’s case study, a female breast cancer patient
is often the primary caretaker of her family. Decisions made concerning her treatment would
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most likely be based on what needs to be done for the entire family system. She would consider
her economic situation in light of her family responsibilities and engage her social support
system in her decision-making (Andrist, 1997; Holmes-Rovner & Charles, 2003).
Limitations of the medical model in the treatment of breast cancer survivors. There
are several limitations to the use of the medical model in treating breast cancer survivors. First,
lack of attention to the person-in-environment does not allow providers to address the impact of
economic barriers, such as healthcare coverage, transportation to appointments and treatment,
and access to prescriptions (Gehlert & Browne, 2006). In a controlled trial of multi-site
community breast cancer screenings of 1599 low income underserved women, findings showed
that economic considerations such as access to care and availability of insurance are often
neglected. Results reveal that the strongest predictor of mammogram screening behavior is a
woman having private health insurance and regular medical services (Hiatt, et al., 2001).
Second, the disruption of family homeostasis is not addressed within the medical model
(Andrist, 1997; Gehlert & Browne, 2006). As with Louise, the inability to carry out her role as
babysitter would affect her grandchildren, her children and their jobs, and her children’s
employers. There are several additional healthcare issues that could disrupt the family. For
example, shorter hospital stays have mandated that recuperation from certain surgeries and acute
medical episodes is conducted in outpatient facilities and at home. These issues may put added
burden on already unstable home situations (Gehlert & Browne, 2006). In addition, breast cancer
is a disease that follows a continuum of phases that require particular psychosocial demands and
developmental tasks for the survivor and the family (Gehlert & Brown, 2006; Rolland, 1994).
Third, family, social and spiritual support systems are not recognized and utilized within
the medical model (Doherty & McCubbin, 1985; Gehlert & Browne, 2006; Webb& Koch, 1997).
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The literature supports the assertion that female breast cancer patients desire the input and
support of their friends, family, and outside medical resources to make informed decisions
concerning treatment (Andrist, 1997; Holmes-Rovner & Charles, 2003; Webb & Koch, 1997).
Fourth, lack of consideration and recognition of the patient as an active participant in the
decision making process disempowers patients (Andrist, 1997). Empowerment, as shown
through qualitative research, enables the patient to have a sense of self-efficacy, encourages the
ability to take action through informed decisions, and provides a sense of connectedness
throughout the treatment process (Davis, Darby, Likes & Bell, 2009; Sharf, 1997; Shields, 1995).
Historically, the medical model has embraced a patriarchal dichotomy of expert doctor to
subordinate patient with little consideration for the patient and her needs, desires, cultural
background, and locus of control (Engel, 1977). The medical model of care is lacking in
providing supportive care for women and their families, especially in the recovery phase of
treatment (Freeman, 2006). Even so, the medical model has not been stagnant through the years
but has evolved to become more inclusive in its approach.
Collaborative Model
Recognition of the whole person is the primary component of the biopsychosocial
approach to health care. According to Engel (1977), this approach addresses the biological as
well as the social, environmental, psychological, and behavioral components of illness and
disease. Thus, the nonmedical components of health are regarded in conjunction with medical or
biological components such as physical examinations, laboratory results, and medical tests
(Gehlert & Browne, 2006). This interactive biopsychosocial model relies on interdisciplinary
collaboration among medical and social scientists to achieve positive health outcomes (Gehlert &
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Browne, 2006; Lindau, Laumann, Levinson, & Waite, 2003). This is the theoretical basis for
collaborative model of healthcare.
Collaborative care is a team approach to delivering evidence-based care (Hedrick, et al.,
2003) that provides an environment in which healthcare professionals can teach one another and
share resources (Sorrells-Jones & Weaver, 1999). Meta-analyses of long term collaborative
treatments reveal that collaborative care is emerging as an effective model of treatment (Gilbody,
Bower, Fletcher, Richards & Sutton, 2006), providing a structure in which to address the
psychosocial needs of the patient, improve health outcomes, reduce costs, and increase access to
available resources and services (Wagner, 2000).
Sommers and associates (2000) investigated the effect of a collaborative approach to care
through an 18-site, controlled cohort study of 543 patients that illustrates the positive financial,
medical, and psychosocial effects of a collaborative approach to healthcare. The intervention
groups received care from a team comprised of primary care, nursing, and social work while the
control groups received usual primary care. The intervention group had significantly lower rates
of hospitalization (0.36 compared to 0.52), fewer primary care follow-ups (decrease of 1.5
compared to 0.5), and increased social activity. There was also a cost savings of $90 per patient
due to the decrease in primary care visits (Gehlert & Browne, 2006; Sommers, Marton,
Barbaccia, & Randolph, 2000).
The fields of medicine, pharmacy, social work, and nursing are key components of
successful collaborative teams (Cott, 1997). These teams may also include physician assistants,
residents, nurse practitioners, dietitians, psychologists, chaplains, administrators and physical,
occupational and speech therapists (Gehlert & Browne, 2006). Meta-analysis of empirical
research as well as individual clinical trials validate the positive aspects of collaborative care in
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the treatment of mental disorders (Chang-Quan et al. 2009; Davies, McBride & Sajatovic,
2008; Katon, et al., 1999), heart disease (Brush, et al. 2009), critical care (Carr, 2009), and
diabetes (McElmurray, et al., 2009; Phelps, et al., 2009).
Collaborative care has evolved to result in three types of healthcare teams.
Multidisciplinary team members represent separate areas of healthcare that are included in the
collaboration yet work autonomously with individual disciplinary languages. Team members of
an interdisciplinary collaboration are more inclusive in that they share their individual
disciplinary languages and bodies of knowledge. Finally, transdisciplinary teams develop a
common shared language based on individual disciplines and compile bodies of knowledge and
theories to jointly achieve new methods and techniques (Gehlert & Browne, 2006; Zerhouni,
2003).
Collaborative care and breast cancer. Helping patients and their families gain access to
services and support throughout treatment and recovery is crucial in improving quality of life for
breast cancer patients and their family systems (Freeman, 2006; Hiatt et al., 2001; Till, 2003).
Medical professionals are often not trained or skilled at identifying or discussing psychosocial
concerns of cancer patients and often assume these problems are a normal component of the
cancer experience (APOS, 2000; Fallowfield, Ratclliffe, Jenkins & Saul, 2001). Fallowfield and
colleagues surveyed 143 physicians to assess their ability to accurately identify cancer patients'
psychological status. Results revealed low sensitivity, high specificity, and high misclassification
(Fallowfield et al., 2001). Sollner and associates had similar findings when evaluating the ability
of eight oncologists to identify psychosocial distress in 298 consecutive patients, where 11 of the
30 patients who were diagnosed to be severely depressed were positively identified by the
practitioners (Sollner et al., 2001).
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A review of patient perceptions and survivor perspectives reflect a lack of provider
attention to the psychosocial needs of breast cancer survivors. In one recent study, screening of
150 consecutive cancer patients identified as having major depressive disorder were assessed to
determine if those patients received evidence-based treatment for depression. Results showed
that half of the patients had discussed symptoms with the healthcare provider, one-third had been
prescribed medication and 15% had received evidence-based therapy, which indicates that
treatment needs for depression were unmet by medical providers (Sharpe et al, 2004). In another
study, sixty women diagnosed with localized or regional breast cancer were interviewed and
assessed via telephone to examine the relationship between perception of diagnostic consultation
and long-term outcomes of psychological adjustment. It was found that physician interpersonal
skills at the diagnostic consultation were associated with later psychological adjustment (Mager
& Andrykowski, 2002).
The medical model’s lack of recognition of psychosocial distress and coping, among
breast cancer survivors reflected in the studies above, hinders the treatment, recovery, and
survival processes of survivors because it hinders patient access to services and supports. The
collaborative model helps medical professionals to achieve desired outcomes because it offers
better attention to patient needs than the medical model. The following chapter will discuss
coping with breast cancer survival among the underserved populations.
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Chapter 3
Coping with Breast Cancer Survival Among the Underserved
Survival phase for the underserved
As previously mentioned, comorbidity, inequality of access to care and discrepancies in
treatment affect the survival rates of underserved breast cancer survivors (Baquet et al., 2008;
Curtis et al., 2008; Newman et al., 2006; Smedley et al., 2003; Tammemagi et al., 2005).
According to review studies (Blackman, & Masi, 2006; Dohan & Schrag, 2005), there are
numerous factors that contribute to health disparities. Among these factors are lower income
(Singh et al., 2003), lack of health insurance (Aziz & Rowland, 2002; Breen, Kessler & Brown,
1996; Lannin et al., 1998; Lannin, Mathews, Mitchell, & Swanson, 2002; Wolff et al., 2003)
irregular source of care (Madnelblatt et al., 1999), low levels of health literacy (Aziz & Rowland,
2002; Davis, Emerson & Husaini, 2005; Husaini et al., 2001; Wolff et al., 2003), cultural beliefs
(Lantz, Dupuis,Reding, Krsuska & Lappe, 1994; Lantz & Reding, 1994; Madnelblatt, Gold, &
O’Malley, 1999; Wolff et al., 2003), and logistic barriers such as transportation, childcare, and
work schedule (Davis, Emerson & Husaini, 2005; Lannin et al., 1998 Lantz et al., 1994; Rojas et
al., 1996; Vernon et al., 1992; Wolff et al., 2003). These factors can affect the ability of
survivors to navigate the continuum of care, cope with a diagnosis of breast cancer and manage
their quality of life during survivorship.
Health related quality of life is an important component of the survival phase of breast
cancer patients, and increased survival rates have peaked interest in this issue (Ashing-Giwa et
al., 2004). Biological, psychological, and social issues that often inhibit optimum quality of life
often mark the transition into the survivorship phase of breast cancer (Kantsiper, et al., 2009). As
a result, the survivor’s quality of life diminishes. The added burden of navigating a system of
treatment that is not meeting the needs of the patient on multiple levels can compound feelings of
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inadequacy in coping and lead to distress (Hewitt, Herdman, & Holland, 2004; O’Hair, et al.,
2003; Rowland, 1990; Rowland, 2006).
Survival Phase Distress
It is estimated that one-third of breast cancer patients experience significant distress
and/or impairment of functioning in their lives (Andrykowski et al., 2002; Coyne, Palmer,
Shapiro, Thompson, & DeMichele, 2004; Hegel et al., 2006). Literature suggests that a diagnosis
of cancer has the potential to result in significant psychological distress (Carver et al., 1993;
Hegel et al., 2006; Hewitt et al., 2006; Michael, Kawaci, Berkman, Holmes, & Colditz, 2000;
Mitchell, 2007; Sanson-Fisher et al., 2000; Stanton, 2006; Stanton & Snider, 1993; Zabora,
BrintzenhofeSzoc, Curboe, Hooker & Piantadosi, 2002). Lack of recognition of psychosocial
distress hinders the treatment, recovery, and survival processes of survivors due to lack of access
to services and support (Sharpe et al., 2004).
Distress is also a factor of quality of life. A descriptive study of 294 breast cancer
survivors that studied quality of life for long term survivors demonstrated that, along with
positive benefits of hopefulness and life purpose, psychological distress, physical issues and
uncertainty of the future were reported (Dow et al., 1996). The effect of decline in cognition can
also have a monumental impact on quality of life (Jansen, 2005; Taillibert et al., 2007). These
women are often caretakers of children and parents as well as full time workers (Abel &
Subramanian, 2008; Staat & Segatore, 2005). Because of the multiple roles that these women
have in their lives, alterations in quality of life affect those around them as well.
Many studies report that distress is related to a woman’s physical and psychological
adjustment to breast cancer and that this distress can be detrimental to decision making,
treatment compliance and outcomes (Allen et al., 2002; Blake-Mortimer, Gore-Felton,
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Kimerling, Turner-Cobb & Spiegel, 1999; Ganz et al., 1993; Ganz et al., 2004; Graves, 2003;
Heim, Valach & Schaffner, 1997; McCaul et al.,1999; Patrick-Miller, Broccoli, Much & Levine,
2004; Schnoll, Harlow, Stolbach & Brandt, 1998; Stanton, 2006; Stanton et al., 2000). The
decision making process is highly stressful as patients are asked to consider an enormous amount
of information, learn a new language and make life-changing decisions. Herein lies the potential
for “information overload” for both the patient and their family, which can set the stage for
maladaptive coping and communication skills.
Merely providing information in the diagnostic stage is insufficient. Survivors react
emotionally to the information and may not be able to fully process what they hear or read
(Walsh-Burke & Marcusen, 1999; Hewitt, Herdman & Holland, 2004). Poor understanding and
communication of information between patient and health care providers creates a barrier to
well-being and increases distress (Blake-Mortimer, Gore-Felton, Kimerling, Turner-Cobb &
Spiegel, 1999; Foley, 1995; Hewitt, Herdman & Holland, 2004; Lerman et al., 1993; Northouse
& Northouse, 1987; Stovall, 2006;).
Evidence suggests that survivors who experience isolation in the early stages of their
decision making are at higher risk of developing and maintaining poor coping skills and
experiencing increased distress throughout their cancer experience (Rowland, 1990; Rowland,
2006). Being able to cope with a diagnosis of breast cancer and the challenges that survival
brings to a patient is an area of breast cancer care that needs investigation, particularly with
regard to whether or not particular underserved populations possess the skills necessary to cope.
Survivor Phase Coping
Coping with diagnosis, treatment and survival of breast cancer is complicated by feelings
of vulnerability (Fredette, 1995), depression and anxiety (Karakoyun-Celik et al., 2009).
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Communication with health professionals and dealing with the diagnosis of breast cancer
prompts information-seeking behavior as a means of coping (Ransom, Jacobsen et al., 2005). In
order to investigate methods of coping through communication, Reaby (1998) studied the
decision making processes of mastectomy patients and reported four coping patterns of decision
making among participants: vigilance (active searching for information), satisficing (being
satisfied with first solution), complacency (acceptance without question or full comprehension),
and defensive avoidance (rationalization and avoidance of discussion) (Reaby, 1998).
The use of social support is a coping mechanism directly associated with health related
quality of life (Danhauer et al.,2009; Filazoglu & Griva, 2008). This method of support can be
adversely affected by misconceptions and negative cultural beliefs held by the support system
(Hamilton, Moore, Powe, Agarwal & Martin, 2010). Even so, social support can benefit from
humor (Johnson, 2002) and spirituality (Ashing-Giwa, 2004; Choumanova, Wanat et al., 2006;
Fredette, 1995; Johnson, 2002; Morgan et al., 2006) when they are used as coping skills to
address physical, emotional, and functional stressors of breast cancer.
Depression and anxiety levels influence the ability of breast cancer survivors to cope with
diagnosis and treatment and affects quality of life (Karakoyun-Celik et al, 2009). In addition,
survivors often face an inefficient health care system, which further compromises survivors’
abilities to make decisions and understand and weigh treatment recommendations (Hewitt,
Herdman, & Holland, 2004; O’Hair, et al., 2003; Rowland, 1990; Rowland, 2006). As previously
mentioned, lacks recognition of patients as an active participant in the decision making process
disempowers them (Andrist, 1997). Empowerment promotes self-efficacy and the ability to make
informed decisions (Davis, Darby, Likes & Bell, 2009; Sharf, 1997; Shields, 1995).
Empowerment allows individuals to manage their lives (Clark & Stovall, 1996; Gray, Doan &
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Church, 1991; Henderson & Thomas, 1987) and emphasizes the fact that individuals understand
their own needs and should be engaged in the various aspects of their health care (Clark &
Stovall, 1996; Clark & Stovall, 2004; Stecher, DeVillis, Becker & Rowenstack, 1986; WalshBurke & Marcusenn, 1999).
Coping Of African American Survivors
African American survivors face unique barriers to successful survival such as cultural
issues revolving around the taboos of discussion of cancer and concerns about access to care
(Kantsiper, 2009). Coping by African American women has been shown to be affected by
perceptions and fears of family and friends and the desire to lessen the burden of loved ones.
These factors can cause women to withdrawal from support due to fear of being ostracized
(Hamilton et al., 2010). Moore (2001) interviewed 23 African American survivors and found that
they lacked both social support and understanding of their unique experiences by those around
them. Studies with African American survivors have also found a lack of culturally–specific
resources for social support, appearance, childcare, financial support, and navigation of the
health care system (Darby, Davis, Likes & Bell, 2009; Davis, Darby, Likes & Bell, 2009; Davis,
Emerson, & Husaini, 2005; Mosavel and Sanders, 2010).
Royak-Schaler and colleagues (2008) investigated patient perception of communication
with providers regarding survivorship care with 39 African American breast cancer survivors.
Their findings included reported gaps in information provided about diagnosis, treatment, and
guidelines for follow-up care despite patient reports of a strong interest in self-care practices and
the receiving of evidence-based information and guidelines (Royak-Schaler, 2008). Davey and
colleagues (2010) conducted focus group interviews of nine breast cancer survivors. Their
findings reveal that patient concerns regarding delivery of care from oncology staff revolved
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around interaction with physicians, power and authority of physicians, family involvement in
treatment and navigation of the medical system (Davey, Kissil, Nino & Tubbs, 2010).
Summary
Over the last two decades, it has been shown that ongoing assessments are beneficial to
identify at-risk breast cancer patients as well as promote self-care that maximizes
biopsychosocial functioning during and after the acute phases of cancer treatment (Bowen et al.,
2007; Ganz, 1995; Ganz et al., 1993; Ganz et al., 1996; Ganz et al., 2004; Ganz, Polinsky, Schag
& Heinrich, 1989; Ganz, Schag, Polinsky, Heinrich & Flack, 1987; Polinsky, Fred & Ganz,
1991; Pollack, Greer, Rowland et al., 2007; Zebrack, Yi, Perersen & Ganz, 2007). Although
research exists regarding the unique barriers that African American women face regarding
coping with issues of breast cancer survival, there is little information regarding whether or not
this particular population possesses the skills necessary to cope with these issues. Two areas
where self-efficacy and coping skills are crucial are health literacy medication adherence.
Barriers to accessing health information and inadequate health care can impede proper
medication usage (Atkins & Fallowfield, 2006; Barber, 2002). Social and environmental barriers
such as a lack of access to help or inadequate knowledge about where to go to receive help
contribute to this dilemma. Empowering breast cancer survivors and their families to gain access
to services and support throughout treatment and recovery is crucial if quality of life for breast
cancer patients and their families is to improve (Freeman. 2006; Hiatt et al., 2003; Till, 2001).
This dissertation posits that methods of empowerment include improving patient understanding
of the merits of proper medication adherence and providing skills to overcome barriers to
achieving medication adherence.
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Intervention methods that favorably influence psychological and social functioning
through enhanced coping skills need to be evaluated and incorporated into practice (Burke &
Kissane, 1998; Clark & Stovall, 2004; Clark & Stovall, 1996; Hewitt, Greenfield & Stovall,
2006; Hoffman & Stovall, 2006; Stovall, 2006; Stanton & Reed, 2006). It is proposedhat such is
the case with providing the skills necessary to cope with the burden of proper medication usage
and adherence, particularly with respect to self-efficacy and level of health literacy.
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Chapter 4
Medication Adherence, Self-Efficacy, and the Role of Health Literacy
Medication Adherence
Description and overview. Medication adherence, or compliance, is the extent to which
patients follow the medication regimens prescribed by healthcare providers. Adherence is the
preferred term because compliance suggests passivity on the part of the patient and a lack of a
therapeutic alliance between patient and provider (Osterberg & Blaschke, 2005; Steiner &
Earnest, 2000). A retrospective analysis of insurance claims confirm the earlier findings that
poor medication adherence is a common problem across most chronic conditions (Their et al.,
2008). Data analysis reveals that poor medication adherence, accounts for 33%-69% of all
hospital admissions, and improper drug therapy accounts for an estimated cost of over $100
billion dollars per year (Osterberg, & Blaschke, 2005). An online survey conducted by Harris
Interactive and The Boston Consulting Group that queried nearly ten thousand adults with
chronic medical conditions revealed that prescriptions were not filled or were taken incorrectly
by respondents due to forgetting (24%), side effects (20%), cost (17%), not thinking the
medication is needed (14%), and inconvenience (10%) (Boston Consulting Group, 2003). These
results are corroborated by the empirical findings discussed below.
Comorbidity and the associated burden of taking multiple medications compound the
problems of proper medication usage. Recognizing the risk of increased drug related problems
among patients being treated for cancer, Puts and colleagues (2009) investigated this issue in a
prospective pilot study of 112 predominately female and newly diagnosed cancer patients
(breast, colorectal, lung, lymphoma, and myeloma) aged 65 and older. Of the participants
screened for participation through medical chart review at a Canadian cancer center, 103 (92%)
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were taking medications. The pharmacy records of 96 patients and self-reports of 12 patients
provided information regarding active prescribed medication. The 18-item Functional
Comorbidity Index was administered to the participants to gather information regarding
additional health issues including arthritis, cardiovascular disease, diabetes, gastrointestinal
disease, vision and hearing impairment, depression, anxiety, and obesity. The median number of
medications per patient was 5 (range 3-9). Potential drug-drug and drug-disease problems were
categorized via computer software, drug monographs, Beers criteria, and published studies.
Computer analysis revealed a total of 247 potential drug problems. Classifications were based on
implications to clinical management: level 1 (most severe) – medication should be avoided, level
2 – medication should be avoided or adjusted to avoid potential problems, and level 3 (least
severe) – evaluate risk. Moderate to severe drug problems were identified in 49 patients (47.6%).
Factors associated with having moderate to severe drug problems were taking 5 or more drugs
and being 76 years of age or older (Puts, et al., 2009).
In order to explore the effects of a client centered approach to medication usage,
Chewning and Sleath (1996) examined the literature with regard to client participation in setting
treatment goals, choosing and evaluating medication regimens, and self care with
nonprescription medications. Their study of the literature led to the conclusion that these tasks
should be the shared responsibility of the patient and the provider, which stands in contrast to the
medical model’s characteristic passive patient and assertive provider paradigm (Chewning &
Sleath, 1996). If patients are to take an active role in the management of their medications, it is
imperative that they have an understanding of the information they are given. These findings
support the use of the collaborative approach to medication management.

27

Collaborative care involving a working relationship between physicians and pharmacists
has been shown, through chart review of patient outcomes and patient case study, to improve
patient care and reduce medication errors (Kuo, Buckley, Fitzsimmons, & Steinbauer, 2004). A
meta-analysis of 37 randomized studies of 12,355 patients diagnosed with depression reported
that collaborative methods to improve medication adherence were more effective than standard
care for improving both short and long term outcomes related to depression (Gilbody et al.,
2006). Collaborative care is beneficial in addressing the psychosocial factors that can affect
medication adherence. The following section provides empirical evidence of such factors.
Measurement of Medication Adherence. Determination of patient adherence to
medication regimens is conducted either directly or indirectly. Direct assessment can involve
direct observation of the patient taking a medication, blood and urine assays, or drug markers
(Andrade, Kahler, Frech & Chan, 2005; Farmer, 1999). Indirect methods include patient or
caregiver self-report through questionnaire, diary or interview, pill counts, electronic monitoring
devices, pharmacy refill records, and insurance claims (Andrade, Kahler, Frech & Chan, 2005;
Farmer, 1999; Garber, Nau, Erickson, Aikens, & Lawrence, 2004; Steiner & Prochazka, 1996).
Although the more sophisticated methods of indirect measure such as electronic records and
electronic monitoring devices are becoming more available and more trusted, they are often not
accessible to small studies and small populations (Steiner & Prochazka, 1996). Questionnaires,
which are the method of measurement for the study, have moderate to high concordance with
other methods. Garber and colleagues (2004) conducted 86 comparisons of self-report to nonself electronic reports of assessments and concluded that questionnaires and diary methods are
preferable to interviews.
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Factors affecting medication adherence. Research literature asserts that there are two
types of medication adherence: intentional and unintentional. Intentional non-adherence involves
a conscious decision not to take medication according to prescribed regimens. This could be due
to cost, side effects, inconvenience, and/or attitudes and beliefs (Atkins & Fallowfield, 2006;
Barber, 2002; Delgado, 2000; Pratt et al., 2001). Intentional adherence can result from the
decision that benefits of medication outweigh risks or side effects (Jacobsen, 2004).
Unintentional non-adherence may be due to forgetfulness, inability to take medication on time,
and/or misunderstanding of how to properly take medications (Atkins & Fallowfield, 2006;
Barber, 2002; Delgado, 2000; Pratt et al., 2001).
Krousel-Wood and colleagues (2009) assert that the multiple barriers to proper
medication adherence include complex medication regimens, inconvenience and treatment of
asymptomatic diseases. This is compounded by the lack of information regarding which patients
are at greatest risk of non-adherence, which barriers influence low adherence and which
interventions are best in overcoming these barriers to improve adherence in specific populations
(Krousel-Wood et al., 2009). The Cohort Study of Medication Adherence in Older Adults was a
prospective study of 2,194 adults aged 65 and older diagnosed with hypertension. Patient
psychosocial behavior, quality of life, clinical factors and their effect on medication adherence
were assessed over a two-year period. Overall, 14.1% of the participants had low medication
adherence, and low adherence was more prevalent in patients who were under the age of 75 and
African American. Additionally, African American participants had a significantly higher
prevalence of uncontrolled blood pressure compared to Caucasian participants (Krousel-Wood et
al., 2009).

29

In a qualitative study of 20 African American women diagnosed with hypertension at an
inner city free clinic, Fongwa and associates (2008) discovered three categories of barriers to
medication adherence: beliefs about hypertension, facilitators of adherence, and barriers to
treatment adherence. Beliefs about the disease were reflected in reported perceptions about what
hypertension is and the concern that hypertensive medication may be addictive or should only be
taken with the presence of symptoms. Among the reported facilitators to treatment adherence
were changes made by the participant, disease knowledge, adherence self-care, and social
support. Barriers to adherence included disbelief of having hypertension, medication side effects,
and environmental factors, such as financial and social issues (Fongwa et al., 2008). Examination
of these categories emphasizes the biopsychosocial aspects of barriers to and facilitators of
medication adherence.
In an effort to measure adherence of antihypertensive therapy and identify factors
associated with adherence, Hashmi and associates (2007) administered the Morisky Medication
Adherence Scale (MMAS), a standardized 8-item self report of medication adherence, to 460
hypertensive Pakistani patients. Over three quarters (77%) of the patients self-reported being
adherent to their drug regimens, and univariate analysis revealed that increased age, better drug
awareness and increased number of medications being taken significantly improved adherence.
Multivariate analysis showed that taking the antihypertensive medication for symptomatic relief
adversely affected medication adherence. (Hashmi et al., 2007). This study reported the issue of
taking chronic medication symptomatically, an issue illustrated in the introduction’s case study.
Improved drug awareness is a factor that implies a higher level of medication knowledge, which
could be due to higher health literacy, but health literacy was not assessed in this study.
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Patient-provider relationships were examined in an assessment of ARV medication
adherence among 946 HIV-diagnosed patients in Sweden (response rate 97.5%). MMAS was
administered along with questions about factors potentially affecting adherence. In addition to
being older and having shorter treatment time, patients classified as adherent (63%) were more
likely to have a good relationship with their healthcare providers (Sodergard et al., 2006). The
importance of patient participation in treatment decisions and goals, as well as effective
patient/provider communication, is reflected in the results of this study. The aspect of duration of
treatment is a variable not routinely addressed and provides added dimension to this study.
The extent of non-adherence among 1,137 Scottish healthcare residents was evaluated
through a 58 item mailed questionnaire, including MMAS, measuring patient self-assessment of
medication risk, adherence, disability, health beliefs, health experiences, and health behavior. Of
the 695 respondents, 645 (61.1%, mean age 78.2 years, SD=7.8) reported currently taking
prescribed drugs. Over one quarter (28.1%) of respondents were non-adherent to their prescribed
drug regimen. Analysis revealed that risk factors for non-adherence were younger age, confusion
about the drugs, lack of access to consistent drug supply and administration, treatment interfering
with lifestyle, and perceived risk outweighing perceived benefits of using medications as
prescribed (George, Munro, McCaig, & Stewart, 2006). As reported in the study by Gatti et al.
(2009) younger age was associated with lower adherence. Access to medication and the nuisance
of taking medication were also reported factors.
Lopes and colleagues (2008) examined medication adherence among 75 patients
diagnosed with metabolic syndrome in a Brazilian university setting. A variation of MMAS was
used to measure adherence, revealing an average level of adherence of 5.44 (SD=0.68) on a scale
of 1.00 to 6.00. This particular study found no statistically significant association between
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compliance and the measured independent variables (access to medication, use of medication,
and level of knowledge of cardiovascular risk factors) (Lopes, Zanini, Casella-Filho & Chagas,
2008). This study could be a reflection of its university setting, where patient education may be
heightened. It may also indicate the need for a separate measure of factors affecting adherence.
Additionally, there may be a cultural factor affecting the high rate of adherence.
Patient beliefs about medication adherence to chronic drug therapy were examined
among participants at an outpatient primary care pharmacy by Phatak & Thomas (2006). MMAS
was administered to measure adherence and BMQ was given to assess beliefs about medications.
Bivariate analysis revealed a positive association between adherence and perceiving the
medications as harmful or as overprescribed by the physician. Patient beliefs about medications
explained a significant portion of variation in adherence (22.4%) (Phatak & Thomas 2006). Here
again the patient’s personal psychosocial attributes are decisive factors in intentional adherence.
Similar issues as those above were examined by Mardby and colleagues (2007), who
analyzed the association between medication beliefs and adherence. BMQ and MMAS measures
were administered to 324 pharmacy clients in Sweden. BMQ measured perceived harm
(General-Harm) and perceived benefit (General-Benefit) of medications as well as beliefs about
whether doctors overprescribed (General-Overuse). Over half of the patients (54%) reported
being non-adherent. There was an association between General-Harm and adherence. Adherence
behavior was associated with more beneficial beliefs about medicines and higher education level
was associated with less harmful beliefs about medicines. Interestingly, users of herbal
medicines and non-users of medicines were more likely to believe that doctors overprescribed
(Mardby, Akerlind, & Jorgensen, 2007). The findings of these two studies (Mardby et al., 2007;
Phatak & Thomas, 2006) emphasize the importance of optimal patient education.
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Odegard and Gray (2008) identified several challenges to properly adhering to
medication among 67 patients diagnosed with diabetes. MMAS and BMQ were administered
during a randomized controlled collaborative diabetes intervention in a clinic setting. The most
prevalent challenges found in this study were paying for medications (34%), remembering
(31%), reading prescription labels (21%), and obtaining refills (21%). Taking more than two
daily doses of medication and difficulty reading prescription labels were significantly associated
with higher hemoglobin A1C, which indicates a poor control of blood sugar. These findings
indicate a need for attention to patient ability to read and understand medical material such as
prescription labels (Odegard & Gray, 2008). The authors noted the implications for
collaboration between the profession of pharmacy and diabetes healthcare providers and
educators. Social work could provide important expertise and resources for the healthcare team
as well.
Medication adherence in breast cancer patients. Analysis of the literature did not
produce much information regarding the investigation of medication adherence among breast
cancer survivors, including those underserved with comorbid conditions. There was little
empirical evidence of using a standardized self-report measure to assess medication adherence
like those used in the studies reviewed above. Even so, analysis of the studies below provides
beneficial information regarding factors that affect medication adherence among breast cancer
survivors, including those dealing with comorbid health issues.
Ridner and Dietrich (2008) studied a convenience sample of 149 breast cancer survivors
to ascertain whether there was difference in type and number of comorbid conditions in patients
with and without lymphedema. Analysis of self-report surveys revealed that survivors with
lymphedema had more comorbid conditions, were older and had lower incomes. No measure of
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adherence to medication regimen was administered, and patients with comorbid conditions that
can cause edema of the limbs were excluded from the study. Of the conditions included, 41
(27%) were taking medications for depression or anxiety, 32 (22%) were taking antihistamines
or using an inhaler, 29 (19%) were taking anti-inflammatory medications, 51 (34%) were treated
for cardiac conditions or hypertension, 24 (16%) were treated for cholesterol, 26 (17%) were
treated for thyroid conditions, and 62 (42%) were treated for osteoporosis (Ridner & Dietrich,
2008). This study illustrates the complex health and drug issues that breast cancer patients may
face in addition to the treatments they may undergo for breast cancer. These issues should be
considered when assessing adherence among this population.
A study by Atkins and Fallowfield (2006) investigated the prevalence of adherence and
factors associated with non-adherence among 131 medically stable breast cancer patients in the
London area. These patients were recruited while waiting for follow-up appointments to assess
the patients’ preferences for routes of administration of breast cancer drugs. Structured questions
were asked to assess non-intentional (“how often do you forget to take your tablets?”) and
intentional (“how often do you choose not to take your tablets?”) adherence to medication. In
addition, an 18-item questionnaire that measured locus of control was administered to assess the
patients’ feelings of self-control over their illness. Mean age was 59.4 years (SD = 11.53), and
52.7% had secondary education or more. Over half (55%) of the patients were non-adherent, and
83.3% reported this non-adherence as unintentional due to forgetting medication. In contrast,
16.7% reported the intentional choice of not taking their medication. Evidence suggested that
intentions for non-adherence were patients’ belief of having significantly less influence over
their own health (Atkins & Fallowfield, 2006). This study did not indicate that the patients did or
did not have comorbid health issues that were being treated with medication. However, feeling a
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lack of control over patient health is a formidable issue to be considered. The psychosocial
aspect of this dilemma needs to be addressed, as the following study illustrates.
Adherence to oral adjunctive therapy is a significant issue for breast cancer survivors that
affects treatment delivery and impairment of health (Ruddy, Mayer, & Partridge, 2009). The
responsibility of proper administration of medication shifts from the healthcare providers to the
patient who may experience barriers to adherence such as cost, complex dosing, and lack of
understanding (Moore, 2010). In order to assess barriers to adherence to oral hormone therapy
among breast cancer survivors, Kirk and Hudis (2008) posted a 30-item online survey developed
by a marketing firm on the Y-Me National Breast Cancer Organization website, now known as
the Breast Cancer Network of Strength (2010), which is a nonprofit organization that provides
information and support for breast cancer survivors. Surveys were completed from 328
respondents during a four-month period in 2005. Three-quarters (75.2%) of the respondents were
ages 41-60. Of those who responded to the questions, 44.2% reported receiving instruction on
proper adherence. Taking therapy as directed was reported by 83.6%, though 57.4% rated their
adherence as excellent (missing no doses in the previous month). Factors that were reported to
increase adherence were management of treatment-related side effects (60.2%) and knowledge of
the benefit of therapy (88.7%) (Kirk & Hudis, 2008). This study did not address any comorbid
conditions that the patient may be dealing with or any other factors that may influence
adherence.
In order to assess the reasons for non-adherence with the adjuvant therapy tamoxifen,
Grunfield and associates (2005) administered the 5-item MARS-5 adherence questionnaire,
BMQ and questionnaires pertaining to its side effects to 110 treated breast cancer survivors.
MARS- 5 was highly correlated with a single question adherence measure (“In the past week
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have you taken your tamoxifen every day?”)(r= 0.497, p<0.001). Using the single item measure
for analysis, 88% were classified as adherers and 12% as non-adherers. The main reason for not
taking tamoxifen, as reported by 46% of the respondents, was side effects of the drug. It is
noteworthy that 18% reported forgetting to take the medication. In general, non-adherers
reported a lower perceived necessity for taking the drug than adherers. The authors mentioned
implications for education by health professionals regarding the importance of proper adherence
(Grunfeld, Hunter, Sikka & Mittal, 2005). As in previously reviewed studies, this research was
conducted without regard to any comorbid issues which the patients may be experiencing.
Discussion. As shown in the studies above, medication adherence is affected by a myriad
of factors. Issues such as access to medications, obtaining information about medications, selfefficacy, stigma, and perceived beliefs about medications and prescribers are a reflection of the
complex biopsychosocial structure in which patients exist. Although it is difficult to assess these
subjective factors, attempts at measuring them and assessing the impact on a patient’s ability or
intent to properly take medications has provided recognition of areas that need to be addressed.
Although one study analyzed above (Lopes et al., 2008) did not find association between
adherence and measured variables, the remaining reviewed studies provided information on
biopsychosocial factors that can impact medication adherence. Patients age 65 and older are
more likely to have better adherence (Hashmi et al., 2007; Krousel-Wood et al., 2009; Pratt et al.
2001; Gatti et al., 2009; George et al., 2006 ). Psychological factors (Diiorio et al., 2009), selfefficacy (Diiorio et al., 2009; Duong et al., 2001), social support (Duong et al., 2001; Fongwa et
al., 2008), and socioeconomic issues (Fongwa et al., 2008; George et al., 2006; Odegard & Gray,
2008) are factors that can impact the ability to adhere to regimens. Race was reported as a
significant factor in only one study (Krousel-Wood et al., 2009).
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Complexity of drug regimens affects adherence (Gatti et al., 2009; Hashmi et al., 2007;
Krousel-Wood et al., 2009), as well as knowledge of the medications and the disease states
(Fongwa et al.; George et al., 2006; 2008; Hashmi et al., 2007; Kirk & Hudis, 2008), education
(Mardby et al., 2007), intention to adhere (2001Atkins & Fallowfield, 2006; Pratt et al., 2001),
remembering to take medication (Atkins & Fallowfield, 2006; Odegard & Gray, 2008) and the
ability to read labels (Odegard & Gray, 2008). Treatment of asymptomatic diseases can pose as a
hindrance to proper medication adherence since the absence of symptoms may lessen the
perceived need for medication for patients with inadequate knowledge about their disease (Gatti
et al., 2009; Krousel-Wood et al., 2009). Coupled with a financial need to make medications last
longer, this type of non-adherence can be detrimental to health. The patient relationship with the
healthcare provider was reported as a factor in adherence, influencing the acquisition of
knowledge and the belief of the importance of adherence (Pratt et al., 2001; Phatak & Thomas,
2006). Patient beliefs about medications regarding side effects (Atkins & Fallowfield, 2006;
Diioria et al., 2009; Duong et al., 2001; Fongwa et al., 2008; Gatti et al., 2009; Grunfeld et al.,
2005; Kirk & Hudis 2008) and harm or benefit of their use was reported as a significant barrier
or facilitator to patient medication adherence (Fongwa et al., 2008; George et al., 2006; Mardby
et al., 2007; Phatak & Thomas, 2006; ).
Self-Efficacy
Definition and Overview. Literature reveals that the manner in which a patient adheres
to a prescribed medication regimen strongly influences health outcomes, health care utilization,
medication knowledge, self-efficacy, and health care costs (Chewning & Sleath, 1996; Delgado
2000). Self-efficacy is based on Bandura’s Social Cognitive Theory, and addresses the personal,
behavioral, and environmental factors of health and disease (Bandura, 1977; Bandura, 1997;

37

Lorig & Holman, 2003). Self-efficacy is defined as the confidence a person has in his or her
ability to take action and to successfully perform that action (Markland et al., 2005;Rimer &
Glanz, 2005). It is the desire and ability to explore, seek to master or seek to adapt to one’s
environment (Ryan & Deci, 2000; Vansteenkiste & Sheldon, 2006). Self-efficacy is considered a
primary factor affecting whether or not a person will change a behavior and has become a
foundation of several behavioral theories (Rimer & Glanz, 2005). Self-efficacy is an essential
component of assessing medication adherence (Risser, Jacobsen & Kripilani, 2007).
Self-Efficacy and Locus of Control. Medication adherence is affected by the combined
influence of self-efficacy and locus of control. Locus of control with respect to health behavior
refers to the belief that health outcomes are controlled by either personal behavior or external
factors (Stecher, DeVellis, Becker & Rosenstock, 1986; Wallston & Wallston, 1984). Internal
locus of control is the belief or perception that one has control over health outcomes, and
external locus of control is the belief or perception that non-behavioral issues control health
outcomes. These perceptions or beliefs may be dissimilar to reality (Ajzen, 2002). Rosenstock
and colleagues (1988) assert that both expectation of outcome due to internal locus of control
and expectation of efficacy are necessary for behavior to take place Rosenstock, Strecher &
Becker, 1988). Figure 1 illustrates the combinations that can occur between locus of control and
self-efficacy.
Self-Efficacy Locus of Control

Low High Internal

Figure 1
Combinations of Self-efficacy and Locus of Control
(Rosenstock, Strecher & Becker, 1988)
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Self-Efficacy and Medication Adherence. Duong and colleagues (2001) discovered that
psychological and behavioral factors are critical in proper medication adherence through a study
of 149 HIV-infected patients on antiretroviral therapy (ARV). The standardized Patient
Medication Adherence Questionnaire (PMAQ), a 61 item self-report of ARV usage, was
administered, and adherence was validated through plasma levels of ARV. Sixteen participants
(11%) were classified as non-adherent. Analysis of questionnaire responses showed that
sociodemographic background, social support, confidence in personal skills, and optimistic
attitude were significantly associated with medication adherence (Duong et al., 2001). The study
emphasized the fact that psychosocial concerns influence medication usage and that
improvement of medication adherence is a multidimensional issue that necessitates a nonlinear,
multidisciplinary approach.
A study of 260 HIV/AIDS patients by Pratt and colleagues (2001) assessed the
psychosocial factors affecting adherence to ARV therapy while comparing three self-report
measures: MMAS, Reported Adherence to Medication (RAM) and Patient Adjustment to
Medication Scale (PAM). Among the significant associations with low adherence were living
alone, feeling depressed, media influence and lack of confidence. Greater adherence was
associated with positive mental attitude about disease. Analysis revealed intentional nonadherence and unintentional non-adherence as two constructs (Pratt et al., 2001). The results of
this study also indicate that when assessing the behavioral aspects of medication adherence the
intent of the individual towards taking medication properly needs to be included in the
assessment.
In a randomized control trial testing of a psychosocial model of medication adherence,
baseline data from a questionnaire administered to 236 predominately male African American
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recruited HIV/AIDS clinic patients were evaluated for personal, social, and provider variables
(Diiorio et al., 2009). Self-efficacy and depression were directly associated with adherence,
while stigma and social support were indirectly associated with self-efficacy and depression
(Diiorio et al., 2009). These findings support the hypothesis that adherence is affected by a
complex, interconnected psychosocial variables, as corroborated by Krousel-Wood et al. (2009).
Gatti and associates (2009) administered MMAS, a measure for health literacy
(REALM), and BMQ to 275 primarily African American patients from an inner city hospital
pharmacy. The average age of the respondents was 53.9 years, nearly 60% of the respondents
read at less than high school reading level and over half (52.7%) had low medication adherence.
Multivariate logistic regression was performed to determine predictors of adherence, patient
characteristics, and characteristics of drug regimens. Among the factors associated with low
adherence were negative medication beliefs, age and low self-efficacy. The authors reported that
patients less than 65 years of age with low medication self-efficacy or negative medication
beliefs reported low medication adherence (Gatti, Jacobson, Gazmararian, Schmotzer, &
Kripalani, 2009). These factors emphasize the psychosocial aspect of medication usage.
Measure of Self-Efficacy in Medication Adherence. There are very few measures
available for measurement of self-efficacy with respect to medication adherence. A new measure
of self-efficacy in medication adherence has recently been developed and was selected as a
measurement for the study. A multidisciplinary team of experts in medication adherence and
health literacy developed The Self-Efficacy for Appropriate Medication Use (SEAMS). It is
developed for use in populations with a broad range of literacy. This measure was used to
conduct an evaluation of psychometric properties with 436 patients with comorbid conditions.
Results show that SEAMS is both reliable and valid as an effective assessment of medication
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self-efficacy in chronic disease management in patients with low literacy (Risser, Jacobsen &
Kripalani, 2007). The SEAMS questionnaire will be discussed further in the methods section of
this proposal.
Summary. It has been previously pointed out that medication adherence can be affected
by multiple interrelated psychosocial factors. Among these factors are Psychological factors
(Diioria et al., 2009), self-efficacy (Diioria et al., 2009; Duong et al., 2001), social support
(Duong et al., 2001; Fongwa et al., 2008), and socioeconomic issues (Fongwa et al., 2008;
George et al., 2006; Odegard & Gray, 2008) . A recent study of 302 adults receiving treatment
for HIV reported that higher self-efficacy in taking medication was associated with higher
medication adherence (Colbert et al., 2012). For the purposes of this study, self-efficacy will be
analyzed and evaluated in conjunction with medication adherence.
The Role of Health Literacy in Medication Adherence
Definition and Overview. Health Literacy is defined as “the degree to which individuals
have the capacity to obtain, process, and understand basic health information and services
needed to make appropriate health decisions” (USDHHS, 2000, p. 11-20). Results from the 2003
National Assessment of Adult Literacy revealed that only twelve percent of the American
population has proficient health literacy, as was measured according to guidelines specified by
the Nationals Research Council’s Board on Testing and Assessment (BOTA) Committee on
Performance Levels for Adult Literacy. Those not having healthcare coverage or insured by
Medicaid or Medicare had lower health literacy (Kutner, M., Greenberg, E., Jin,Y., & Paulsen,
2006).
Health literacy is a critical factor in patient-provider communication, positive health
outcomes, and provision of optimum health care (Jeppesen, Coyle, & Miser, 2009; Williams,
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Davis, Parker, & Weiss, 2002). Health literacy affects all areas of health. Individuals with low
health literacy have poorer health (Baker, Parker, Williams, & Clark, 1997; Baker et al., 2002),
greater stigma or shame (Parikh, Parker, Nurss, Baker & Williams, 1996; Parker, Baker,
Williams & Nurss, 1995; Baker et al., 1996), higher rates of hospitalization (Baker et al., 1997;
Baker, Parker, Williams, & Clark, 1998; Baker et al., 2002; Gordon, Hampson, Capell, &
Madhok, 2002), and higher healthcare costs (Friedland, 1998; Howard, Gazmararian, & Parker,
2005).
Patients with low health literacy and chronic medical conditions are less likely to
properly manage their conditions due to decreased knowledge (Kalichman, Ramachandran, &
Catz, 1999; Kalichman & Rompa, 2000; Schillinger et al., 2002; Schillinger et al., 2003;
Williams, Baker, Honig, Lee & Nowlan, 1998; Williams, Baker, Parker & Nurss, 1998;), which
includes lack of knowledge about the proper use of medication (Gatti et al., 2009; Georges,
Bolton & Bennett, 2004; Ngoh, 2009). Edwards and colleagues (2012) assert that health literacy
skills can be developed over time in patients with long-term conditions and that this skill can
enable these patents to become more active participants in their healthcare (Edwards, Wood,
Davies, and Edwards, 2012). The body of literature devoted to the association of measured
health literacy with medication adherence is small and contains many limitations. The following
section will address the importance of health literacy in medication adherence.
Health Literacy and Medication Adherence. Fang and associates (2006) illustrated the
benefits of a collaborative approach to the treatment of a specific patient population. This study
administered S-TOFHLA, a modified version of the Test of Functional Health Literacy in
Adults, to 179 ethnically diverse, low-income clinic patients taking the anticoagulant drug
warfarin. Limited health literacy was associated with limited knowledge of medication.
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However, after adjusting for control variables (age, sex, race/ethnicity, education, cognitive
impairment and years taking warfarin) multivariate logistic regression revealed no significant
association between limited health literacy and patient-reported missed doses (Fang, Machtinger,
Wang, & Schillinger, 2006). This study is representative of a collaborative care model providing
verbal and written education of the medication as well as follow up meetings at each visit in
conjunction with regular monitoring of laboratory values of warfarin levels under the supervision
of a cardiologist. These factors may explain the lack of association between health literacy and
medication adherence in this study.
Roth and Ivey (2005) interviewed 100 patients (mean age 77.5, SD=8.7 years) enrolled in
the North Carolina Eldercare assistance program to determine medication usage and identify
potential problems. S-TOFHLA was administered and found that adequate health literacy was
present in only 35% of participants. Results of the 4-item Morisky adherence questionnaire
revealed non-adherence in 53%. Poor health literacy, non-adherence and improper use of the
medications posed several potential problems such as poor health outcomes, increased health
costs, decrease in physical functioning and poorer quality of life (Roth & Ivey, 2005).
Persell and associates (2007) explored the relationship between patient identification of
medication, health literacy and reconciliation between self-report and medication record with
119 nurse-referred patients diagnosed with hypertension at three primary care clinics in
Michigan. S-TOFHLA was administered to assess health literacy. Patient responses to questions
regarding medications were compared to chart records of medications prescribed. Nearly onethird (31%) of patients had inadequate health literacy and were less able to name their
antihypertensive medications than those with adequate health literacy (40.5% vs. 68.3%, p=
0.005), with the difference remaining after adjustment for age and income. Furthermore,

43

agreement between patient report and record report of medication usage was lower for patients
with inadequate health literacy compared to those with adequate health literacy. The inadequate
health literacy group had a higher percentage of African-Americans, persons with lower income
and persons who had obtained less education. Health literacy was not associated with reported
number of medications (Persell, Osborn, Richard, Skripkauskas & Wolf, 2007). .
In order to investigate the association of low health literacy with poor glaucoma
medication adherence, Muir and colleagues (2006) administered surveys, including the REALM
measure, to 197 patients who were awaiting appointments at a university eye center (Muir et al.,
2006). Medication adherence was measured by contacting pharmacies to determine six-month
refill history. Of the 163 participants prescribed medication, adherence was assessed with 142 of
the participants. Over half (52%) of participants scored at a reading level of eighth grade or
lower and 23 (11.7%) read at third grade level or below. Refill requests were not predicted by
race, gender, age or education level as determined by linear regression and analysis of variance.
There was a significant positive relationship between health literacy and the number of refills
obtained for glaucoma medication (Muir et al., 2006). Among the barriers to proper medication
adherence was the reported poor understanding of the disease among the participants, which
indicates a need for proper education of the importance of treatment of glaucoma by the
healthcare professionals (Muir et al., 2006). Two studies used the same population to address the
issues of HIV medication adherence, health literacy and confounding factors among 204 patients
receiving care at multisite infectious disease clinics across the United States (Waite et al., 2008;
Wolf et al., 2007). REALM was administered as well as Patient Medication Adherence
Questionnaire (PMAQ), a standardized measure of patient medication usage among HIV
patients. In addition to medication adherence, PMAQ was used as a measure of self-efficacy and
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social stigma. Results show that patients with low health literacy were 3.3 times more likely to
be non-adherent to retroviral medication regimens. Wolf and associates (2007) report that patient
self-efficacy mediates the impact of low health literacy on improper medication adherence to an
HIV regimen (Wolf et al., 2007). Additionally, perceived stigma was found to be a mediating
factor between health literacy and medication adherence, reducing the effect of health literacy by
40% (Waite et al., 2008).
In order to examine health literacy with respect to HIV medication adherence, Kalichman
and associates (2008) conducted a four-month cross sectional study of 145 predominantly
African American patients who were either referred or volunteered for the study. Health literacy
was measured through the administration of TOFHLA, and medication adherence was measured
by unannounced telephone-based pill counts. Medication adherence was poorer in those with
lower health literacy, and lower health literacy explained variance in medication adherence more
than years of education, emotional distress, internalized stigma, social support and alcohol use.
(Kalichman et al., 2008).
Reported inadequate health literacy ranges from 31% (Persell et al, 2007) to 65% (Roth
& Ivey, 2005). Additionally, there is a statistically significant relationship between health
literacy and medication adherence (Juzych et al., 2008; Kalichman et al., 2008; Muir et al, 2006,
Persell et al., 2007; Waite, et al., 2008; Wolf et al., 2007). Patient self-efficacy (Wolf et al.,
2007) and perceived stigma (Waite et al., 2008) are mediating factors between health literacy and
medication adherence. Further, inadequate health literacy is associated with race, income, and
education (Juzych et al., 2008; Persell, et al., 2007).
A recent review of the literature examined English language articles pertaining to health
literacy and medication adherence in older adults taking medications for diabetes or
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cardiovascular illness. Of the 7 studies included in the analysis, one study reported a confirmable
association between health literacy and medication adherence (Loke et al., 2012).
Breast cancer survivors are at risk for inadequate healthcare services, lower health
literacy, and improper medication adherence. There is a gap in research regarding these risk
factors for this population. Further, empowering survivors to learn how to seek and ask for
information concerning proper medication usage is an under-researched topic that needs to be
examined.
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Chapter 5
Theoretical Framework
Theoretical Framework of Dissertation Study
As previously mentioned, the medical model of health care is not conducive to meeting
the unique needs of breast cancer survivors. Pychological distress and socioeconomic issues can
compound the overwhelming obstacles that breast cancer survivors are expected to overcome.
One such issue is the management of medication adherence while working within the patient’s
level of health literacy. Collaboration among health care providers with the patient provides the
opportunity for social workers and pharmacists to work together on the education of proper
medication usage, screening for health literacy, providing access to resources and identification
of barriers to proper medication use. It is important for social workers to be aware of patterns of
medication adherence, and it is equally important for pharmacists to be cognizant of health
literacy issues. All those in the chain of providing healthcare, particularly social workers and
pharmacists, must be aware of the psychosocial barriers that hinder medication adherence. The
collaborative framework and team approach is the best fit for achieving this outcome.
No one theory embodies the ideal conceptual framework in which to examine the
constructs of knowledge, attitudes and barriers of medication adherence (Wu, 2008). Several
health behavior change models address the importance of motivation for change and improving
processes that effect change, as well as recognize the psychosocial roles of self-efficacy, social
support, decision processes and perception of relevance and susceptibility (Emmons & Rollnick,
2001). This research was conducted within a collaborative framework and examined issues of
health literacy and medication adherence with the population of underserved breast cancer
survivors through the lens of the Health Belief Model. Within this model, the theory of Self-
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Determination was the foundation on which the hypotheses were tested through. The first
subsection will provide a brief overview of the Health Belief Model (HBM) as it pertains to the
study. The second subsection will examine Self Determination Theory (SDT) with respect to its
biopsychosocial aspects and the ways that the theory relates to empowerment and self-efficacy.
Health Belief Model. One of the oldest theories of health behavior, HBM was born in
the 1950’s by the US Public Health Service to explain the lack of population participation in
programs to detect and prevent disease. Social psychologists theorized that people’s beliefs and
perceived benefit influenced the readiness to act (Rimer & Glanz, 2005). Through the years the
model has been expanded to include six constructs: 1) percieved susceptibility, 2) perceived
severity, 3) perceived benefits, 4) percieved barriers, 5) cues to action, and 6) self-efficacy
(Rimer & Glanz, 2005). These constructs along with definitions and strategies for change are
listed in Figure 2 below.
The primary focus of HBM is motivation for health. It is a suitable framework for
examining short and long-term behavior change strategies within the health care fields. This is
accomplished while keeping in mind the feelings of target populations towards health problems,
their perceptions of the severity of the problems, and whether their actions can reduce the threat
of severity (Rimer & Glanz, 2005). HBM has been the catalyst for studies researching
medication adherence, predicting patient beliefs concerning their conditions and possible
outcomes and the impact of beliefs on medication usage (Ownby, 2006). Medication adherence
within the framework of HBM has been examined in patients with health issues and disease
states that include mental disorders (Baloush-Kleinman et al., 2002; Dolder & Lacro, 2004;
Fenton, Blyler & Heinssen, 1997; Osvath, 2010; Perkins, 1999; Sapra,Vahia, Reyes, Ramirez &
Cohen, 2008; Zeber, Grazier, Valenstein, Blow & Lantz, 2007), HIV (Cox, 2009; Ferguson et
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al., 2002), cardiovascular disease (Garavalia et al., 2009, Jacobsen, 2004), diabetes (Park et al.,
2010), and dementia (Ownby, Hertzog, Crocco, Duara, 2004).

Concept

Definition

Potential Change Strategies

Perceived susceptibility

Beliefs about the chances of
getting a condition

•
•
•

Perceived severity

Perceived benefits

Pereceived barriers

Cues to action
Self-efficacy

Beliefs about the
seriousness of a condition
and its consequences
Beliefs about the
effectiveness of taking
action to reduce risk or
seriousness
Beliefs about the material
and psychological costs of
taking action
Factors that activate
“readiness to change”
Confidence in one’s ability
to take action

•

Define what population(s) are at risk and
their levels of risk
Tailor risk informationn based on an
individual’s characteristics or behaviors
Help the individual develop an accurate
perception of his or her own risk
Specifiy the consequences of a condition
and recommended action

•

Explain how, where, and when to take
action and what the potential positive
results will be

•

Offer reassurances, incentives, and
assistance; correct misinformation

•

Provide “how to” information, promote
awareness, and employ reminder systems
Provide training and guidance in
performing action
Use progressive goal setting
Give verbal reinforcement
Demonstrate desired behaviors

•
•
•
•

Figure 2
Constructs of the Health Belief Model (Rimer & Glanz, 2005)
HBM and Breast cancer. Despite the limitations of HBM noted by Ashing-Giwa
(1999), HBM has been used as the theoretical framework with African American breast cancer
survivors in the evaluation of early detection (Barruso et al., 2000; Douglass, Bartolucci,
Waterbor & Sirles, 1995 ), mammography (Champion & Scott, 1997; Champion et al., 2008;
Champion & Springston, 1999; Erwin, Spatz, Stotts, Hollenberg & Deloney, 1996; Farmer,
Reddick, D’Agostino & Jackson, 2007; Russell, Champion & Skinner, 2006), self-examination
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(Champion & Scott, 1997; Erwin et al., 1996; Graham, Liggons & Hypolite, 2002) and beliefs
and perceptions (Gullate, 2006; McDonald et al., 1999; Sadler, G. R., et al. 2007).
Limitations to HBM. As previously mentioned, research of medication adherence
among breast cancer survivors, particulary the underserved, is extremely limited. Consequently,
application of the Health Belief Model in this population with reference to medication adherence
is limited as well. However, in the afformentioned studies, the beliefs and perceptions of the
populations studied have significant influence on medication usage (Atkins & Fallowfield, 2006;
Grunfeild, et al., 2005; Kirk & Hudis, 2008; Moore, 2010).
As noted by Ferguson and colleagues, HBM may have limitations when addressing the
adherence issues of people of color and women with respect to psychosocial barriers to
adherence (Ferguson et al., 2002). Ashing-Giwa (1999) provides even further insight into the
limitations that may exist when addressing the unique needs of African American breast cancer
survivors with respect to mammography screening. Although she agrees that the constructs are
helpful in explaining influences of screening practices, there are limitations to the model. First,
perceived barriers may not convey the reality of this population. There is an underlying
assumption of what the barriers are and these may not be the true barriers. Second, assumptions
are made about risks and concerns associated with perceived susceptibility and severity that may
not be applicable to African American women. Many women of this population do not perceive
themselves to be at risk. Third, the author asserts that assumptions of personal control over
health status and disease embedded in HBM are inconsistent with the data of the survival of
African American breast cancer patients. Finally, this population lives in a collective
environment where percieved personal risk is assessed within the context of group risk (Ashing-
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Giwa, 1999). The following section will examine these limitaitons in light of a modified Health
Belief Model.
Expanded HBM. Expansion of the HBM has provided a more comprehensive
framework in which to evaluate the subjective and individual factors that influence adherence to
medication regimens. Sapra and colleagues (2008) employed a modified HBM to examine the
subjective, clinical and psychosocial factors that were associated with medication adherence
among 198 community dwelling patients diagnosed with schizophrenia. Their findings revealed
that lower education, increased medication side effects and higher depression scores were
associated with higher scores of influence of others (Sapra et al., 2008). An earlier literature
review of medication adherence in schizophrenic patients resulted in the description of a
modified health belief model in which medication related factors as well as social support and
the quality of the therapeutic alliance between patient and providers affect adherence and
offered areas in which to individualize the approach to patient care (Fenton, Byler & Heinssen,
1997).
In his evaluation of adherence of statin medication regimens in cardiac patients, Jacobsen
(2004) employed the use of a modified HBM that merits consideration for this study. Figure 3
provides a diagram of this model. The following section will examine this particular modified
HBM as it applies to the paramaters of the study and will use the case study presented at the
beginning of the paper to illustrate its application.
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Benefits of treatment
Decreased symptom
Frequency/severity

Risks of Illness
Insight
Belief that symptoms
persist
Belief that one is at risk
for symptoms

Prevention of hospitalization/
other unwanted events
Enhanced therapeutic
relationship

Costs of Treatment
Adverse events
Costs
Inconvenience
Psychological effects

Perceived severity of symptoms

LIKELIHOOD OF ADHERING TO TREATMENT RECOMMENDATIONS

Barriers

Cues to Act

Health care system inadequacies
Lack of transportation
Financial difficulties
Disease related barriers
Cognitive impairment/disorganization
Paranoid delusions/suspicions
Substance abuse
Complex regimen

Medication provided by another person
Visually prominent placement of
medication container
Pill boxes
Alarm watches
Appointment reminders
Symptom exacerbation

Figure 3
Modified Health Behavior Model. Adapted from Jacobsen, 2004
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Application of modified HBM to study.
Benefits of treatment. Treatment of asymptomatic diseases is challenging for health care
professionals. Louise does not have a perceived susceptibility to the adverse consequences to
improper adherence. She may also be examining the benefits of taking medication for an
asymptomatic disease if the medication makes her feel worse. Her adherence to tamoxifen, even
though it produces side effects, may be due to the desire to prevent a recurrance of breast cancer.
Risks of illness. As illustrated by the case study, Louise does not comprehend the risk of
her diabetes and hypertension because the absence of symptoms cause her to percieve a lack of
severity. She may be dealing with the belief that she is not at risk for the covert symptoms of
hypertension and diabetes. These issues are compounded by psychosocial issues and her lack of
use of resources.
Costs of treatment. The costs of the medication not covered by Tenncare are treatment
issues that Louise must take into consideration, as is illustrated by her strategies to make the
medications last longer. Psychological effects of treatment may be an issue that Louise deals
with due to the repercussions of prolonged chemotherapy and radiation. She may be
experiencing depression and cognitive issues that need to be addressed. Furthermore, Louise is
coping with the inconvenience of complicated drug regimens.
Barriers. Louise experiences several barriers to adequate adherence. Being the primary
caretaker for two children is challenging, especially for a 58 year-old woman who is enduring the
challenges of breast cancer treatment and questionably controlled asthma. In addition, she faces
financial difficulties and cognitive issues with remembering to take the complex medication
regimen she is required to take. This is further compounded by her lack of adequate health
literacy to understand the information given her.
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Cues to act .The benefits of having a cue such as the pillbox are overshowdowed by the
barriers that exist in Louise’s life. She has resources available through healthcare providers at the
pharmacy and the clinic, but her lack of self-determination and her inability to successfully
communicate with her providers renders these resources useless at the present time.
HBM, medication adherence, and health literacy. No one theoretical framework
encompasses the multiple issues that affect the medication usage of patients. Each person
presents a unique set of biopsychosocial factors that influence the propensity to adhere or not
adhere to medication regimens. Even so, HBM provides a goodness of fit for the study. Patient
beliefs are the most influential set of factors affecting medication adherence (Veazie & Cai,
2007). Even so, perceived severity, perceived benefits, recognition of barriers and beliefs of
outcomes are affected by access to information and the ability to understand it. Davis et al.
(2002) posit that patients with low health literacy respond to interventions and provision of
information within the framework of HBM. It is within this framework that precedence is given
to actions and motivation based on empowerment. Davis further asserts that patients with low
health literacy desire information that enhances their sense of well being and helps with solving
immediate health problems (Davis et al., 2002; Doak, Doak & Root, 1996).
Motivation to adhere is not always an objective and rational decision. Subjective
perceptions of risk and benefit often contribute to the decision making process. These individual
assessments include the perceived social norms, group norms and the consequences and
acceptability of proposed behavior (Van Dulman et al., 2007). Veazie & Cai (2007) assert that
patient sense of uniqueness is a moderating factor in individual information processing. This
belief in oneself contributes to self-determination and the motivation to change behavior. This
study employed Motivational Interviewing (MI) in the intervention phase and used Self-

54

Determination Theory (SDT) as its theoretical framework. The following section will provide a
brief overview of SDT as it applies to Motivational Interviewing.
Motivational Interviewing and Self-Determination Theory
Motivational interviewing. Originally developed as a method of treating alcohol
addiction (Miller, 1983), MI is defined as a “client-cented, directive method for enhancing
motivation to change by exploring and resolving ambivilance” (Miller & Rollnick, 2002, p. 25).
There are five main principles of MI: 1) expression of empathy, 2) develop discrepency, 3) avoid
argumentation, 4) roll with reisitance and 5) support self-efficacy (Miller & Rollnick, 1991). MI
is developed from a clinical perspective and strives to encourage the patient to be a proactive
participant in the process of change (Vanseenksite & Sheldon, 2006). It is defined as a style of
therapy rather than a specific technique ( Miller, 1996). MI was developed without a theoretical
basis (Britt, Hudson & Blampied, 2004; Hettema, Steele & Miller, 2005; Markland, Ryan, Tobin
& Rollnick, 2005; Miller & Rose, 2009). There is considerable support for the use of SelfDetermination Theory as a theoretical framework for MI. The following sections will provide a
brief overview of Self-Determination Theory (SDT) followed by the rationale of applying SDT
to MI in the study.
Self Determination Theory. SDT focuses on the inner resources of the individual for
personality development , behavioral self-regulation and self-motivation (Markland et al., 2005;
Ryan, 1995; Ryan & Deci, 2000; Ryan, Kuhl & Deci, 1997). SDT is a broadly based theory of
human motivation that conceptualizes the general conditions that support or weaken motivation
(Markland et al., 2005; Vansteenkiste & Sheldon, 2006). Since the theory was developed from
field and experimental investigations of the effect of external events on intrinsic motivation
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(Deci & Ryan, 1980; Markland et al., 2005), SDT also recognizes the social and environmental
factors that contribute to the motivation of an individual (Ryan & Deci, 2000).
According to SDT there are three psychological needs – competence, autonomy, and
relatedness – that are innate and necessary for self-motivation (Markland et al., 2005; Ryan &
Deci, 2000). First, competence, or self-efficacy, is the desire and ability to explore and seek to
master or adapt to one’s environment (Ryan & Deci, 2000; Vansteenkiste & Sheldon, 2006), and
a confidence in one’s ability to carry this out (Markland et al., 2005). Second, autonomy is
described by Ryan and Dec as regulation by the self (Ryan & Deci, 2006). Autonomy brings
with it the belief that one has a choice in a situation (Vansteenkiste & Sheldon, 2006). Third,
relatedness refers to the need to expereince a connectedness to others through satisfying and
supportive social relationships (Markland et al., 2005). Although autonomy and relatedness may
appear to be antagonistic to one another, Ryan and Deci (2000) assert that within the framework
of SDT, autonomy refers to a feeling of volition separate from an independent or dependent
context.
SDT hypothesizes that motivation and behavior can be conceptualized as a continuum of
autonomy that indicates a person’s endorsement of and commitment to behavior (Markland et
al., 2005; Ryan & Deci, 2000). Figure 2 illustrates this concept in relation to type of behavior,
type motivation, and type regulation, and the extrinsic factors that may augment or undermine
the motivational process (Cook & Fielding, 2010; Ryan & Deci, 2000).
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Figure 4
Continuum of autonomy. Adapted from Ryan & Deci (2000) and Cooke and Fielding (2010)

Amotivation is an unwillingness to comply or behave in a certain way. There is either no
action or no intent to act . There is no self-determination involved, and there is no external or
internal regulation (Ryan & Deci, 2000). The only type autonomous motivation that is
completely internalized is intrinsic motivation. This motivation comes from within a person and
produces actions and behavior that are done purely for the enjoyment and self-satisfaction of the
individual (Markland et al., 2005; Ryan & Deci, 2000; Vansteenkiste & Sheldon, 2006). It is
entirely self-determined and no external factors or regulation affect the motivation or outcome.
Between these two extremes of the continuum lie four categories of extrinsic motivation where
external factors - cues, praise, rewards, punishments, threats - either enhance or deter a desired or
anticipated behavior. The type of extrinsic motivation approaching the fully autonomous intrinsic
motivation is integrated regulation, where the person has conscious value of the goal or behavior
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and it is considered in line with personal core beliefs (Markland et al., 2005; Ryan & Deci,
2000).
According to empirical findings (Deci & Ryan, 1985) there are specific behaviors
associated with autonomy support for engaging in behaviour, which include: 1) developing a
personally meaningful rationale, 2) minimizing external controls (rewards and punishments, 3)
providing opportunities for participation and choice, and 4) acknowledging negative feelings
(Markland et al., 2005). Furthermore, the need for relatedness is imperative for the successful
internalization of motivation (Deci & Ryan, 2000). To summarize, a feeling of competence does
not guarantee motivation or engagement This must occur within a context of self-determination
in an environment conducive to providing autonomy support and fulfilling the need for
relatedness and connectedness (Markland et al., 2005). Providing these parameters in an
encouraging environment that supports the improvement of internalized motivation is a
foundational aim of MI (Foote, 1999). The following section will discuss the application of SDT
to MI.
Application of SDT to MI. Motivation is not a singular concept but rather a fluid
paradigm affected by values, coercion, commitment and fear (Ryan & Deci, 2000). Motivation
to change is an even more complex phenomenon. Self-determination theory provides a
theoretical framework in which to examine the psychological processes of motivational change
(Foote et al., 1999). Since MI is, by origin and design, atheoretical (Britt et al., 2004; Hettema et
al., 2005; Markland et al., 2005; Miller & Rose, 2009), there is a need to determine the best
theoretical fit for the study. Both SDT and MI have a similar apporach to human nature and
treatment and possess the common origin of birth from practice (Vansteenkiste & Sheldon,
2006).
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There are several reasons for the “goodness of fit” between theory and practice. First,
both SDT and MI share the assumption that patients possess the potential for change and a
natural tendency towards personal development (Markland et al., 2005; Vansteenkist & Sheldon,
2006). Second, MI and SDT both posit that treatment is not a prescriptive activity in which the
therapist or counselor directs the process of change. Both regard the change process as
originating within the patient or client who draws on his or her own motivation (Vansteenkist &
Sheldon, 2006). Third, SDT and MI advocate an approach to treatment and change that is free of
content. The focus is on the how, or manner, of the tratment rather than what is actually being
presented (Vansteenkist & Sheldon, 2006). Thus, there is no set “cookbook” method for goal
attainment (Markland et al., 2005).
MI fulfills SDT’s requirement for satisfaction of needs (Ryan & Deci, 2000), thus
providing a framework in which the patient is the expert in his or her experience and is heard in a
facilitative atmosphere where relatedness is promoted, autonomy is vital, and competence is
encouraged (Markland et al., 2005). Provision of clear information, helping the patient to expect
realistic outcomes, and providing positive, non-judgemental feedback support the need for
competence. Support for autonomy is given through avoidance of confrontation (rolling with
resistance) and coercion, exploring options and developing discrepency between current
behavior and desired outcomes in order to choose a course of action. Relatedness is made
possible in MI through the warmth, interest, and unconditional support provided by the facilitor
(Markland et al., 2005). Figure 4 illustrates the parallels between the social and environmental
factors of SDT and the principles of MI.
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Figure 5
Self-Determination Theory and Motivational Interviewing. Adapted from Markland et al. (2005)
Methodology
Evidence for MI. Motivational interviewing was developed to treat patients with alcohol
abuse (Handmaker, Miller & Manicke, 1999; Heather , Rollnick , Bell & Richmond, 1996;
Miller, 1996; PMRG, 1993; PMRG 1997; Sellman, Sullivan , Dore , Adamson & MacEwan,
2001) and was later expanded for treatment of chemical depencency (Martino, Carroll, O’Malley
& Rounsaville, 2000; Saunders, Wilkinson & Phillips, 1995; Stephens, Roffman & Curtin,
2000; Stotts, Schmitz, Rhoades & Grabowski, 2001; van Bilsen, 1991; van Bilsen, 1995; ). This
method of treatment functions on the premise of working through feelings of ambivalance about
behavior change (Resnicow et al., 2002). MI has since been used to affect change across
disciplines for treatment of weight control (Woollard et al., 1995), mammography screening
60

(Ludman, Curry, Meyer & Taplin, 1999) smoking cessation (Emmons, Hammond, Velicer,
Evans & Monroe, 2001; Rollnick, Butler & Stott, 1997; Valanis et al., 2001;), exercise adherence
(Harland et al., 1999) and eating disorders (Killick & Allen, 1997; Schmidt & Treasure, 1997;
Treasusre & Ward, 1997).
A meta-analysis of 72 randomized control trials was conducted by Rubak and colleagues
(2005), examining studies using MI as intervention in the areas of alcohol abuse, psychiatric
issues, addiction, diabetes, asthma, weight issues and smoking cessation. Their findings revealed
that MI outperformed traditional interventions aimed at giving advice in approximately 80% of
the studies. There were no reports of MI causing harm or adverse effects. MI was effective in
single as well as multiple sessions with encounters as brief as 15 minutes. Limitations of the
review with respect to the study are threefold. First, there was limited reporting of group
interventions, which is the format of the study. The majority of the studies used individual
interviews (n=68), while three of the studies used group therapy where no effect was shown.
Second, none of the studies measured medication adherence as an outcome. Third, there was no
report of interventions conducted by a pharmacist (Rubak, Sanbaek, Lauritzen, & Christensen,
2005).
Although empirical literature is limited (Possidente, 2005), there is mounting evidence
that MI is an effective treatment intervention in medication adherence, particularly within the
areas of mental illness (Coffey, 1999; Kemp et al., 1998; Reniscow et al., 2002; Swanson ,
Pantalon & Cohen, 1999; Zygmunt et al., 2002), HIV and antiretroviral therapy (DiIorio et al.,
2003; Safren et al., 2001), diabetes (Doherty & Roberts, 2002;), and asthma (Schmaling, Blume
& Afari, 2001). There were no studies found that specifically dealt with randomization of breast
cancer survivors with the intent of evaluating medication adherence and health literacy through
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an intervention based on MI. However, there are reports of randomized control trials (RCT) with
aspects similar to the study and will be discussed below.
Randomized control trials, Motivational Interviewing, and Medication Adherence.
In order to examine the effectiveness of therapy addressing medication adherence among patients
diagnosed with psychotic disorders in an acute treatment setting, Kemp and colleagues (1996,
1998) randomly assigned 74 patients to receive four to six sessions of compliance therapy
employing techniques of MI or non-specific counseling, tested in two studies, and followed over
18 months. Booster sessions of both treatments were offerd at 3, 6, and 12 months. Outcome
measures included observer-rated adherence attitudes to treatment, insight into illness, and social
functioning. In both studies, patients in the MI group showed significantly greater improvements
in attitudes to treatement with medication, better insight into their particular illness and increased
medication adherence compared to participants in group with non-specific counseling (Kemp,
Hayward, Applewhate, Everitt & David, 1996; Kemp, Kirov, Everitt, Hayward & David, 1998).
There are, however, some limitations to the study with respect to the study. First, the setting of
the study limits its generalizability. Second, limiting assessment of adherence to subjective
rating by the observer limits the input of the participant. These limitations apply to another study
conducted by Hayward and colleagues (1995) in which MI was used with 21 randomly assigned
hospitalized patients diagnosed with schizophrenia or affective disorder. The intervention group
(n=10) received two to three sessions of MI. Attitudes toward medications, measured by standard
questionnaire, were improved in the intervention group, though not statistically significant
(p=.35) (Hayward, Chan, Kemp, Youle & David, 1995). However, results should be taken with
caution due to the small sample size.
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A review of the literature revealed the use of MI in RCT’s involving populations on
antiretroviral (ARV) therapy. The complicated nature of these medication regimens lends
themselves to investigation regarding adherence patterns. DiIorio and colleagues (2003)
randomly assigned 20 patients on ARV medications to either a control group or an intervention
consisting of three counseling sessions by a MI-trained nurse. Adherence was measured by two
standardized questionnaires (UCSF Adherence Questionnarie, The Antiretroviral Adherence
Scale). Statistical significance was achieved for only one measure of adherence. The majority of
the intervention group (83%) agreed that discussing motivation, confidence and values regarding
medication usage was helpful. However, a smaller percentage of the intervention group reported
being unable to take medications as recommended by their providers (x2=5.13, p=.024) (DiIorio
et al., 2003). These results should be taken with caution due to the small sample size.
DiIorio later conducted a RCT of primarily low-income men and women with HIV in a
clinic setting in Atlanta (DiIorio, 2008). The intervention group (n=125) received five sessions of
MI through individual counseling by a nurse. The control group contained 122 participants.
Medication adherence was assessed using the Medication Event Monitoring System (MEMS)
from baseline up to 12 months. Patients in the intervention group showed a weak trend of higher
mean percent of prescribed doses taken and a greater percent of doses taken on schedule. These
trends were observed beginning at the eighth month of assessment until the final month (DiIorio,
2008).
A study by Samet and colleagues (2005) randomized and assessed 141 HIV-infected
patients and employed MI techniques to address medication adherence. This multicomponent
intervention was not associated with change in adherence. The sample also had a history of
alcohol problems and assessment of alcohol consumption did not reveal any changes both at
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short and long term follow-up. This led the authors to conclude that high risk populations need to
have adherence issues addressed with supervised medication delivery or simplified regimens
(Samet et al., 2005).
There are a limited number of studies using MI with a study design similar to this present
study. Safren et al. (2001) conducted a study using patients on ARV medicaitions in a
community setting with 56 HIV-infected patients. Patients were randomly assigned to selfmonitoring (n=26) or Life-Steps (n=30), a one-session intervention combining cognitivebehavioral and problem solving techniques along with MI. Adherence and depression were
assessed by questionnaire at baseline, two weeks, and 12 weeks post intervention. Patients in the
Life-Steps program who presented with adherence problems at baseline showed faster
improvements in adherence than in the self-monitoring group, and improvement appeared to be
maintined three months after the intervention. Greater depressed mood accounted for 13% of
variance in all adherence scores (Safren et al., 2001).
Ogedegbe and colleagues (2007, 2008) tested the effectiveness of MI on medication
adherence among 190 African American participants with uncontrolled hypertension. The
control group received standard care while the intervention group received standard care plus
four sessions of MI at three month intervals. Adherence to antihypertensive medication was
measured via MEMS and Morisky self-report. Secondary measures were changes in blood
pressure, self-efficacy, and motivation between baseline and 12 months. Results revealed a
steady maintenance of adherence in the intervention group compared to a significant decline in
the control group (Ogedegbe et al., 2007; Ogedegbe et al., 2008).
In a cluster randomization study of patients with Type 2 diabetes, intervention
participants received MI through a one day course with two half day follow ups during the first
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year (Rubak, Sandbaek, Lauritzen, Borch-Johnsen & Christen, 2011). Both the intervention and
control groups received intensive treatment of type 2 diabetes. After the first year, there was
significant improvement in metabolic status (HbA1c, p<.01) in both groups. In addition,
medication adherence was close to 100% in both groups. The authors concluded that the results
were possible due to the physicians’ use of core elements of MI in the control group and lack of
use of the maximum allowable MI sessions by the intervention groups (Rubak et al., 2011).
Lastly, Schmaling and colleagues (2001) conducted a randomized pilot study to examine
the effect of MI on adherence to asthma medications. In this study, 11 patients received MI (one
30-60 minute session) plus education and 14 received education alone. Outcome measures were
questionnaires aimed at assessing readiness to change with regards to asthma treatment, but there
was no direct measure of medication adherence. Findings revealed that MI and education
combined was more likely to show stable adherence or an increased level of readiness to adhere
to medication regimens over time (Schmaling, Blume & Afari, 2001); however, results should be
taken with caution due to the small sample size.
Summary
The overarching collaborative model of health care upholds the assertion that this study
must be conducted with the combined efforts of social work and pharmacy. These two
disciplines provide the complimentary and cohesive expertise to examine medication adherence
and health literacy from a biopsychosocial perspective. With this perspective in mind, it stands to
reason that examination of medication ahderence must be conducted with the recognition of
patient beliefs, self-efficacy, literacy level and perception of barriers. This is accomplished
through the application of HBM. The HBM framework recognizes that the patient herself is the
expert of her own situation. Furthermore, use of SDT as the theoretical basis for MI is part of the
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foundation for the study. Figure 6 provides a visual interpretation of the the theories presented in
this paper and how each relates and intersects with regard to the study.
Although the study contains multiple factors that need to be addressed, the examination
of each of these factors will provide information about the charactericstics and needs, of a
population of overlooked and underserved women who struggle to have their voices heard and
needs met.

Collaborative Model of Health Care
(Medication Adherence/Health Literacy)

Health Belief Model
(Medication Adherence)
Self-Determination Theory
(Method of Motivational Interviewing in
Educational Workshop Format)

Figure 6
Theoretical Framework of Study
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Chapter 6
Methodology
Preliminary Study
Pre-dissertation investigation of health literacy and medication adherence was conducted
in June, 2009. This preliminary qualitative research was conducted with underserved African
American breast cancer survivors who are members of the same population that was used for the
dissertation study. Two focus groups were conducted for a total of 24 participants. Age range of
the participants was 30-75, and the time since diagnosis ranged from one to five years. Issues
involving health literacy, medication adherence, medication side effects, cognitive issues and
difficulties accessing resources were addressed.
Thematic analysis revealed a lack of uniformity in access to medication information, high
self-reported health literacy among participants and frustration at the inconsistency in medication
coverage due to individual insurance medication formularies. Participants reported taking
multiple medications for comorbid diseases, which affected medication understanding and
adherence. Additional concerns included side effects and complications of medications, lack of
support from health professionals regarding insurance issues and lack of support following
completion of acute treatment of breast cancer. Participants also reported cognitive disabilities
due to chemo brain (Rust & Davis, 2013). Overall, there was a reported lack of clearly defined
patient-specific psychosocial services provided by social workers and other healthcare
professionals.
This preliminary study emphasizes the assertion that a lack of consideration for and
recognition of the patient as an active participant in the decision making process disempowers
the patient (Andrist, 1997) and does not utilize the patient’s knowledge of her personal situations
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(Clark & Stovall, 2004; Walsh-Burke & Marcusenn, 1999; Stecher et al., 1986). This inhibits her
ability to make informed decisions and reduces her connectedness throughout the treatment
process (Davis, Darby, Likes & Bell, 2009; Sharf, 1997; Shields, 1995).
This dissertation was developed based on the information garnered in the preliminary
study and built on the previous study’s emphasis on empowerment and self-efficacy through the
utilization of the Health Belief Model and Self-Determination Theory. The following sections
will describe the research design and methods of the study.
Objectives and Hypotheses
Based on the assertions given in addition to the discussion of the literature provided, the
following study was based on the following objectives and hypotheses:
Primary Objectives
Objective 1: To evaluate the efficacy of a medication adherence skills intervention alone
compared to a medication adherence skills intervention in conjunction with a cancer skills
psychoeducational program in increasing medication adherence for underserved African
American breast cancer survivors.
Hypothesis 1.1: Underserved breast cancer survivors provided with cancer survival skills
training plus medication adherence skills training in a psychoeducational group setting
will report significantly better medication adherence compared to survivors provided with
medication adherence skills training only or those receiving no intervention at 4-6 month
follow-up.
Hypothesis 1.2: Underserved breast cancer survivors provided with medication
adherence skills training only in a psychoeducational group setting will report
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significantly better medication adherence compared to survivors receiving no
intervention at 4-6 month follow-up.
Objective 2: To evaluate the efficacy of a medication adherence skills intervention alone
compared to a medication adherence skills training in conjunction with a cancer skills
psychoeducational program in increasing self-efficacy in medication adherence for underserved
African American breast cancer survivors.
Hypothesis 2.1: Underserved breast cancer survivors provided with cancer survival skills
training plus medication adherence skills training in a psychoeducational group setting
will report significantly better self-efficacy in medication adherence compared to
survivors only provided with medication adherence training or those receiving no
intervention at 4-6 month follow-up.
Hypothesis 2.2: Underserved breast cancer survivors provided with medication
adherence skills training only in a psychoeducational group setting will report
significantly better self-efficacy in medication adherence compared to survivors receiving
no intervention at 4-6 month follow-up.
Secondary Objectives
Objective 1: To collect data to determine whether there is a relationship between health
literacy and medication adherence and between health literacy and self-efficacy.
Objective 2: To collect data for future analysis to be conducted on the psychosocial
factors (e.g. depression, quality of life) impacting medication adherence.
Research Design and Methods
Experimental Design. This pilot study utilized a three-arm, randomized, repeated
measures, experimental design. The rationale for implementing a randomized experiment was
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to utilize the random assignment to control most threats to internal validity. This ensured that
the intervention groups and control group were initially statistically equivalent, making
implausible such threats to internal validity as selection bias, providing a basis for valid causal
inferences. Since the recruited participants were volunteers, there was no random selection of the
population of breast cancer survivors, which makes inferences about the entire population
uncertain. Randomization also allows for statistical control of extraneous or spurious variables
(Rubin & Babbie, 2008). Furthermore, the repeated measures that were collected over a 4-6
month period allowed for analysis of trends as illustrated by previously cited studies (DiIorio,
2008; Safren et al., 2003). IRB approval for this study was obtained from the University of
Tennessee IRB (See appendix). Figure 7 illustrates the design of the study.
Research Participants & Study Site. The study sample consisted of an intervention
group (n=23) of cancer survival skills (CSS) training, which included medication adherence
skills training, one intervention group (n=24) of medication adherence skill training only (MTM)
and one control group (n=24) with a total study population of 71 participants. Eligibility
requirements were that all participants must be 1) female, 2) African-American, 3) underserved,
4) self-identified as being diagnosed with breast cancer, 5) within 1 year of acute treatment, 6) at
least 18 years of age and 7) provide written consent (initial or name) to participate. All
participants were compensated for participation with gift cards from a choice of Wal-Mart or
Kroger.
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Figure 7
Study Design

Recruitment. Participants were primarily recruited by the staff of the Carin’ and
Sharin’ Organization in Memphis, Tennessee through events, website, flyers and physician
referral. Carin’ and Sharin’ is a community-based organization for underserved and minority
women diagnosed with breast cancer. It provides breast health education,
supportive services, medical referrals, case management, transportation and
financial assistance to underserved women diagnosed with breast cancer. Interested participants
were initially screened by personnel to ensure that all participants met eligibility requirements.
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Eligible participants were randomly assigned to either the intervention groups or control
group. Visits were conducted by staff of Carin’ and Sharin’ to obtain a signed informed consent
and baseline data. Training was provided to the research staff by Dr. Cindy Davis, and Connie
Rust, principal investigator for the dissertation study. This training was a one-day workshop in
Nashville, Tennessee that covered randomization, recruitment, data collection, program
implementation, and the importance of consistency and continuity throughout the study.
Recruitment for the groups was slower and more difficult than anticipated. Additional
participants for the MTM group were recruited through contacts with the American Cancer
Society in Knoxville, Tennessee and Chattanooga, Tennessee as a means to ensure equivalency
in group numbers. Methods of recruitment and randomization remained consistent at these sites.
Informed consent and baseline data were obtained at these sites either prior to the workshops or
via home visits.
Design of intervention. Upon acceptance, participants were assigned a number in order
of inclusion into the study. This number corresponded to the number of a specific folder. Due to
the timing of the project, participants were first recruited and randomized to the CSS group and
control group and then recruited and randomized to the MTM group and the control group.
Group 1 (CSS) received medication adherence skills training following a six-week course
of cancer survival skills training and Group 2 (MTM) received medication adherence skills
training only. Group 3 (control) received no intervention (i.e., standard care). The skills training
workshops are described below.
Intervention Group 1:Cancer Survival Skills Training (CSS): Group 1 first received a
6-week series of skills workshops conducted via psychoeducational group sessions led by a
trained oncology social worker and one session on medication adherence skills training led by a
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licensed pharmacist. The three subgroups (n=23) were conducted consecutively and met weekly
for seven weeks for two-hour sessions. These intervention groups were a small group format.
There were three groups with no more than 10 participants per group. Meals were provided, and
transportation was provided for those who needed it. The oncology social work group facilitator
implemented the Cancer Survival Skills Training adapted from the Cancer Survival Toolbox
Training Manual (NCCS, 2006). In order to increase consistency in the groups, the same
oncology social worker conducted all of the skills training sessions. (See Intervention Protocol
below)
Intervention Group 2: MTM ONLY: Group 2 received only one session consisting of
the materials covered in Week 7 on MTM (See Intervention Protocol below). This group was
also a small group format (four groups) with no more than 9 participants per group. Meals were
provided, and transportation was provided for those who needed it.
The CSS and MTM workshops were facilitated by an oncology social worker. Guest
speakers provided additional information to the participants. The same speakers were used
throughout the study to help ensure continuity. MTM workshops conducted in Memphis were
conducted by Dr. Lawrence Brown, PharmD.. MTM workshops in Knoxville and Chattanooga
were conducted by Ms. Rust, who is a licensed pharmacist (D.Pharm) and holds her master’s
degree in social work (MSW). Ms. Rust was assisted by an MSW student in Chattanooga, and
assumed the dual role of oncology social worker and presenter in Knoxville.
Control Group. The control group received standard care as usual with no skills trainings
during the study. At the end of the study, the control participants received handouts on
medication adherence and a copy of the Cancer Survivor Toolbox. These handouts were identical
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to those distributed to the participants of the intervention groups. The control group was not
denied any standard services during this study.
Intervention Protocol

Week 1: Toolbox Session I - Communicating
1. Welcome and introductions
2. Information gathering
3. Introduction to self-advocacy
4. Introduction to the Cancer Survival Toolbox
5. Communication skills (e.g, being assertive, using "I" messages, active listening, checking the
message, and expressing feelings
6. Exercises
7. Completing evaluation forms & Closing
Week 2: Toolbox Session II - Information Seeking
1. Welcome and introductions
2. The importance of information
3. Finding information
4. Computer assisted exercises
5. Completing evaluation forms & Closing
Week 3: Toolbox Sessions III - Decision-Making
1. Welcome and introductions
2. The importance of decision-making for survivors
3. Experiential exercises (e.g., identifying decision-making style & weighing the pros & cons)
4. Completing evaluation forms & Closing
74

Week 4: Toolbox Session IV - Problem-Solving
1. Welcome and introductions
2. Introduction to problem-solving
3. Steps to problem-solving
4. Managing discouragement
5. Completing evaluation forms & Closing
Week 5: Toolbox Session V - Negotiating
1. Welcome and introductions
2. Introduction to negotiating
3. Negotiation skills
4. Insurance benefits and employee rights
5. Completing evaluation forms & Closing
Week 6: Toolbox Session VI - Standing Up for Yourself
1. Welcome and introductions
2. The importance of standing up for your rights
3. Exercises
4. Examples of how survivors have learned to stand up for their rights
5. Completing evaluation forms & post-test
Week 7: Medication Adherence Skills Training (MTM) The MTM workshop is described below.

Medication Adherence Skills Training (MTM). This workshop consisted of a two-hour
group workshop conducted by a licensed pharmacist. The pharmacist covered proper medication
usage, communication skills on how to discuss medication usage with health care professionals,
and how to overcome barriers to proper medication adherence. Even though the population of the
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study was restricted to breast cancer survivors, many of the participants were taking medications
for comorbid diseases. The workshops were designed to address issues that may be encountered
while taking multiple medications for various acute and chronic conditions. The rationale for
providing this type format was to address the issues of health literacy and medication adherence
within a collaborative framework, increase participant confidence in accessing necessary
resources for improved medication usage and enhance personal self-efficacy regarding health
care.
The MTM workshop was developed based on standardized training materials that focus
on proper medication usage. The interventions were conducted using the techniques of
Motivational Interviewing (MI). As previously stated in the literature review, MI is a method of
enhancing motivation for change through the resolution of ambivalence (Miller & Rollnick,
2002). Defined as a style of therapy rather than a technique (Miller, 1996), schools of thought
have differed in regard to use of manual-driven techniques, but emerging literature considers the
use of MI to be a fluid process that is impeded by employing scripted workshops (Emmons &
Rollnick, 2001; Hettema, Steele & Miller, 2005). For this reason, the interventions used were not
a scripted format, although all of the targeted issues were addressed. The interventions followed
the five main principles of MI: expressing empathy, developing discrepencey, avoiding
argumentation, rolling with reisitance, and supporting self-efficacy (Miller & Rollnick, 1991).
The workshops lasted approximately 2 hours and followed the following agenda:
1. Welcome and introductions
2. Introduction to medication adherence
3. Skills to improve adherence and health literacy
4. Identification to barriers to proper medication usage and adherence
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5. Exercises
6. Closing
Items 3-6 employed elements of the protocol of Life-Steps, a single-session intervention
utilized by Safren and colleagues (2001) to address adherence issues with HIV medications. This
intervention used cognitive-behavioral, problem solving and motivational interviewing
techniques to address issues of adherence (Safren et al., 2001). The following sections will
examine each of the components: communication with providers, obtaining medications,
adherence and review.
Communication with providers. Through techniques of MI, participants were given the
opportunity to verbalize the opportunities and barriers that exist regarding communication with
health care providers, particularly pharmacists. The need for the participants to be well-informed
about their medications through collaboration with providers was stressed.
Obtaining medications. Access to medications was discussed, including the need to
inform providers when obtaining medications is difficult. Anticipated barriers to accessing
medications were addressed, such as transportation to pick up medications, lack of insurance,
high costs of medications and forgetting to have medications filled or refilled.
Taking medication, successful adherence, and slips in adherence. Cues for taking
medication, storage, medication schedules and slips in adherence were addressed. Behavior
modification strategies (WHO, 2010) were incorporated into the workshops to explore successful
adherence. These strategies included skill building and reinforcement, organizational skills, selfmanagement skills, coping with side effects and utilization of social supports and family
members. Within this strategy, it was important to appeal to the emotional aspect of the
participants and make them feel empowered to make a difference in their situation (WHO, 2010).
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Review. The review portion of the workshop was used as a time for wrapup, questions
and answers, and a recap of the topics that had been covered. The review also included
provision of handouts: 1) “Ask Me 3,” a brochure developed to help in communicating with
health care providers (NPSF, 2011) and 2) “My Medicines,” a personal medication record with
advice and tips on how to take medication correctly (FDA, 2012).
Measures. In addition to demographic data, questionnaires were administered to measure
patient self-efficacy in medication usage, medication adherence and a three question measure for
health literacy. These measures were given pre-intervention (baseline) and at 4-6 months post
intervention via face-to-face interviews.
The Adherence to Refills and Medications Scale (ARMS) is a reliable and valid scale with
good performance in populations with chronic diseases and low literacy. The measure has high
internal consistency and high correlation with older standardized measures (Krippalani, Risser,
Gatti & Jacobson, 2009). (ARMS questionnaire in appendix.) This measure for medication
adherence is a 12 item, 4 point Likert scale measure with a possible composite score range of 448. Item 12 was reversed scored. Lower scores indicate better medication adherence. Analysis of
pretest scores revealed high reliability (Cronbach’s alpha = .82).
The Self-Efficacy for Appropriate Medication Use Scale (SEAMS) is a validated selfreport scale measuring patient confidence in the ability to take medications properly. The
measure has high internal consistency and strong criterion-related validity (Risser, Jacobson &
Kripalani, 2007). This measure for self-efficacy is a 13 item, 3 point Likert scale measure with a
possible composite score range of 3-39. Higher scores indicate better self-efficacy. Analysis of
pretest scores revealed high reliability (Cronbach’s alpha = .91).
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The three question measure for health literacy was developed and validated with
REALM and S-TOFHLA, which are older and longer measures of health literacy (Chew,
Bradley & Boyko, 2004; Wallace, Rogers, Roskos, Holiday & Wiess, 2006). The shorter, three
item measure was chosen due to the large number of questionnaires being administered to the
participants and the fact that it could be given orally if needed.
In addition to these questionnaires, a post workshop survey questionnaire measure was
given at the completion of the MTM workshops. This questionnaire provided immediate
feedback on the day of the workshop regarding the participants’ perception of the intervention.
The rationale for using this questionnaire was to maintain uniformity among the skills workshop.
Surveys were administered at the completion of each skills workshop. Each survey was a 4 item
Likert scale questionnaire. Possible survey responses ranged from 1 (not at all) to 5 (a great
deal).
Additional data was collected on quality of life, depression and positive growth from a
cancer experience. However, this data will not be utilized to address the current hypotheses in the
study. This data will be utilized in later analyses to address the role of psychosocial factors in
medication adherence.
Data collection and data entry
Data for baseline and posttest data were collected via face to face interviews with
participants. Data collection was conducted in Memphis by the same social workers throughout the
study via home visits. Data in Chattanooga was collected by Ms. Rust and her assistant via home
visits and on site collection prior to workshops, and data in Knoxville was collected by Ms. Rust in
the same manner. Upon completion of the posttest data, folders were collected and prepared for
data entry. A trained research assistant entered all data for all participants, thus allowing for
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continuity and decreasing the possibility of data entry error. Data was entered into SPSS and data
analysis was conducted using SPSS.

Timeline
Table 1 provides the timeline that was followed for the study.
Table 1
Timeline of Study

Recruitment of participants

December, 2010 – October, 2011

Administration of pretest questionnaires

February, 2011 – March, 2012

Implementation of intervention

April, 2011- March 17, 2012

Collection of posttest data

May, 2011 – July, 2012
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Chapter 7
Results
Statistical analysis
Descriptive. Demographic information was analyzed with descriptive statistics. Patient
response to demographic questions regarding comorbid disease states and medications were
analyzed according to number of disease states and number of medications. Data on individual
disease states and individual medications was also collected and will be used for future analyses.
ANOVA. Analysis of the study data with respect to the hypotheses was conducted using
repeated measures analysis of variance (ANOVA). The assumptions for repeated measures of
ANOVA are that 1) there is a continuous dependent variable, 2) there is approximate normal
distribution of the dependent variable, 3) sphericity, or the variance of the differences of all
levels are equal and 4) there is at least one independent variable where participants are tested on
the same dependent variable at least two times (Laerd Statistics, 2012).
These assumptions were problematic but not impossible for a study of such small size.
Several steps were taken to minimize the problems. The recruiters screened potential participants
to make sure that they met eligibility criteria. The pharmacists and oncology social workers were
trained to apply the treatment consistently in each workshop. The rigorous design of this project
was done to reduce the possibility of outliers in the data, thus increasing the probability of
satisfying the assumptions.
Post hoc data analysis. The three questions in the health literacy questionnaire were
treated as three individual variables in addition to analyzing the composite score. Repeated
measures ANOVA were used to analyze the three health literacy questions and group assignment
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to determine a relationship between interventions and health literacy. The post workshop survey
was analyzed using frequency measures.
Descriptive analysis
Completion status. A total of 71 women began the study. Seventy women participated in
pretest data collection. Throughout the course of the study 4 participants withdrew for unknown
reasons, 2 were unable to attend and 3 died. The number of women completing the study was 62.
Group assignment and completions status. Treatment group 1 (CSS) was assigned 24
participants, Group 2 (MTM) was assigned 24 participants and Group 3 (Control) was assigned
23 participants. A total of 62 women completed the study – 18 in the CSS group, 24 in the MTM
group and 20 in the control group. Of the CSS group, 3 withdrew for unknown reasons, and 3
were unable to attend. Of the control group, 1 withdrew for unknown reason, and 3 died. The
table does not reflect attrition in the MTM group. This is due to the fact that all participants
completed the study except one. She could not be located for the follow-up posttest completion
and was not included in the study.
Age and age at diagnosis. The mean age of the participants was 54.14 years of age
(SD=9.70). The mean age at diagnosis was 51.85 years (SD=9.64).
Number of people living in household. The mean number of people living in household
was 2.39 (SD = 1.61). Eighty percent (n=63) had 0 to 3 people living in their household. Eight
participants (11.3%) had four people, 3 (4.2%) had five, 2 (2.8%) had 7 and 1 participant (1.4%)
had 8 people living in her household.
Education. The mean number of years of school completed was 13.44 (SD=2.70). Nine
(12.7%) of the participants did not finish high school. Over one-third of the participants (36.6%)
82

completed high school, 19 (26.8%) had earned an Associate’s or technical degree, twelve
(16.9%) a college degree, 3 (4.2%) a masters degree and 1 (1.4%) a doctoral or professional
degree.
Employment status. Nearly one quarter (24.3%) of the participants were unemployed.
Twenty-one (30%) were receiving disability benefits, and 15 (21.4%) were retired. Fourteen
participants (20%) were working full time, and 3 (4.3%) part time.
Household monthly income. Over half (61.5%) of the participants reported a monthly
household income as under $2000 (<$1000-$4999). One quarter (25.7%) reported $2000-$4999,
and the remaining respondents (12.7%) reported a monthly household income as over $5000.
Stage of cancer. As per enrollment criteria, all participants were self-reported African
American breast cancer survivors. Of those who reported their stage of cancer (n=46), nearly one
quarter (34.8%) of the participants were diagnosed as having Stage 2 breast cancer, 28.3%
reported having Stage 1, and those having Stages 3 and 4 were both 17.4% of the participants.
Medications and comorbidity. The mean number of medication was 3.8 (SD=2.86).
Reported comorbid diseases were high blood pressure (60%, n=42), heart disease (11.4%, n=8),
stroke (2.9%, n= 2), diabetes (31.4%, n=22), arthritis (41.4%, n=29), and osteoporosis (8.6%,
n=6).
Insurance. Three of the participants (4.3%) had no insurance. Over one-third (40.6%)
had private insurance. Twenty-five of the participants (36.2%) had TennCare, and 9 (13%) had
Medicare.
Table 2 summarizes descriptive analyses of demographic data by group. Table 3 provides
results of bivariate analyses of demographic data by group. Based on mean values of insurance,
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employment status, and household monthly income, approximately half of the sample appeared
to be underserved.

Table 2
Descriptive Analyses of Demographic Variables by Group
Total

CSS

MTM

Control

Mean(SD)
N
Age of
participant

Mean(SD)

N

70

54.14(9.70)

23

66

51.85(9.64)

22

Years of
school
completed

70

13.44(2.70

Number of
medications

56

3.80(2.86)

Number of
children

70

Number in
household

70

Age at
diagnosis

2.58(2.18)

2.39(1.61)

Mean(SD)
N

53.30(7.64)

Mean

N

p

24

51.1(9.98)

23

58.2(10.25)

.04

49.95(7.75)

22

48.64(9.60)

22

49.95(7.75)

.01

23

12.70(1.80)

24

14.08(2.30)

23

13.52(3.62)

.21

19

4.21(2.70)

16

3.06(2.74)

21

4.00(3.10)

.47

23

2.43(1.80)

24

2.17(1.27)

23

3.08(3.07)

.34

23

2.30(1.49)

24

2.63(1.76)

23

2.22(1.60)

.66

Table 3
Bivariate Analyses of Demographic Variables by Group
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Total (n/%)

CSS (n/%)

MTM (n/%)

Control (n/%)

Insurance
Private
TennCare
Medicare
None
Other
Total*

28(40.6)
25(36.2)
9(13.0)
3(4.3)
3(4.3)
69(100)

5(22.7)
11(50.0)
2(9.1)
2(9.1)
1(4.5)
22(31.9)

14(58.3)
6(25.0)
2(8.3)
0(0)
2(8.3)
24(34.8)

9(39.1)
8(34.8)
5(21.7)
1(4.3)
0(0)
23(33.3)

Stage of Cancer
1
2
3
4
5
Total

13(28.3)
16(34.8)
8(17.4)
8(17.4)
1(2.2)
46(100)

3(27.3)
1(9.1)
3(27.3)
3(27.3)
1(9.1)
11(23.9)

5(26.3)
10(52.6)
1(5.3)
31(15.8)
0(0.0)
19(41.3)

5(31.2)
5(31.2)
4(25.0)
2(12.5)
0(0.0)
16(34.8)

x2
.182

.215

Marital Status

.304

Married
Divorced
Widowed
Single
Other
Total

27(38.6)
15(21.4)
8(11.4)
19(27.1)
1(1.4)
70(100)

9(39.1)
3(13)
2(8.7)
9(39.1)
0(0)
23(32.9)

12(50.0)
4(16.7)
2(8.3)
5(20.8)
1(4.2)
24(34.3)

6(26.1)
8(34.8)
4(17.4)
5(21.7)
0(0)
23(32.9)

Employment
Unemployed
Disability
Retired
Part time
Full time
Total

17(24.3)
21(30.0)
15(21.4)
3(4.3)
14(20.0)
70(100)

9(39.1)
8(34.8)
2(8.7)
1(4.3)
3(13.0)
23(32.9)

4(16.7)
9(37.5)
7(29.2)
1(4.2)
3(12.5)
24(34.3)

4(17.4)
4(17.4)
6(26.1)
1(4.3)
8(34.8)
23(32.9)

.183

Household
monthly income
<$1000
$1000-1499
$1500-1999
$2000-4999
>$5000
Total

.235
13(18.6)
14(20.0)
16(22.9)
18(25.7)
9(12.9)
70(100)

6(26.1)
2(8.7)
8(34.8)
6(26.1)
1(4.3)
23(32.9)

Comorbidity
Blood pressure
Heart disease
Stroke
Diabetes
Arthritis
Osteoporosis

42(60.0)
8(11.4)
2(2.9)
22(31.4)
29(41.4)
6(8.6)

13 (56.5)
1(4.3)
1(4.3)
10 (43.5 )
11(47.8)
3(13.0)

2(8.3)
5(20.8)
5(20.8)
8(33.3)
4(16.7)
24(34.3)

14 (58.3)
3(12.5)
0(0)
2 (8.3)
8 (33.3)
0(0)

*3 cells (50.0%) have expected count less than 5
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5(21.7)
7(30.4)
3(13.0)
4(17.4)
4(17.4)
23(32.9)

15(65.2)
4(17.4)
1(4.3)
10 (43.5)
10 (43.5)
3(13.0)

.82
.37*
.58*
.01
.58
.18*

Comparative analyses of demographic data by group. Demographic variables were
analyzed by group assignment to determine the success of randomization.
ANOVA. ANOVA was conducted to determine differences among demographic data
between groups. Analysis showed significant main effects in age (p=.036, F=3.50, df = 2) and
age at diagnosis (p=.00, F= 5.37, df=2). Post hoc Bonferroni tests showed significant variance in
age between the control group and MTM groups, with the mean age of the MTM group (51.1
years) being younger than the control (58.2 years) (p=.04). There was significant variance for
age at diagnosis between the CSS group (50.0 years) and the control group (57.0 years) (p=.04),
and the MTM group (48.6 years) and the control group (p=.01). Levene’s test showed no
significant variance between groups with respect to all of the variables except for number of
years of school completed. Analysis showed no significant difference between the groups with
respect to number of people living in the household, years of school completed and number of
medications taken (p>.05). Table 2 above summarizes the findings.
Chi-square. Chi-square analyses were conducted between groups with respect to
insurance, stage of cancer, marital status, employment and household monthly income. The
analyses failed to indicate a significant difference for all of the variables. The sample size was
not large enough to meet an expected cell frequency of five. Chi square tests were performed to
determine if the indicated variables were distributed differently with respect to group
assignment.
Additional analyses were conducted between groups with respect to comorbidity (high
blood pressure, heart disease, stroke, diabetes, arthritis and osteoporosis). The test failed to
indicate a significant difference for all of the variables except for one. Patients with comorbid
diabetes showed significant difference by group (x2=9.04, p=.01). Crosstab analysis showed that
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8.3% of the MTM group (n=2) were diagnosed with diabetes while 43.5% (n=10) of the CSS and
control groups were diagnosed. Table 3 above summarizes the findings. Participants with a
diagnosis of the comorbid disease are presented (n and percent of within group). Variables with
cells having an expected count less than 5 are identified.
Analysis of Dependent Variables by Group Assignment. ARMS and SEAMS. Pretest
means of composite scores of the dependent variables (ARMS and SEAMS) were analyzed by
group assignment. Baseline scores revealed no significance difference in mean scores for the
ARMS or SEAMS among the CSS, MTM, and CSS groups. Table 4 summarizes these findings.
Table 4
ANOVA analysis of ARMS and SEAMS scores by Group assignment
CSS (n)

MTM(n)

Control(n)

p

ARMS1

15.74(23)

17.75(24)

18.67(24)

.08

SEAMS1

32.83(23)

30.42(24)

32.67(24)

.30

Testing of Hypotheses
Hypotheses 1.1 and 1.2
Hypothesis 1.1: Breast cancer survivors provided with cancer survival skills training
plus medication adherence skills training in a psychoeducational group setting will report
significantly better medication adherence compared to survivors provided with medication
adherence skills training only or those receiving no intervention at 4-6 month follow-up.
Hypothesis 1.2: Breast cancer survivors provided with medication adherence skills
training only in a psychoeducational group setting will report significantly better medication
adherence compared to survivors receiving no intervention at 4-6 month follow-up.
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Results. Hypotheses 1.1 and 1.2 were tested using the ARMS questionnaire as the
repeated measure dependent variable. Question 12 was reverse scored and the total composite
score for the ARMS questionnaire was used in the data analysis. Reapeated measures ANOVA
showed that there was no statistically significant difference within groups. Consequently, no
analysis between groups was warranted. Results are summarized in Table 5 and Figure 8.
Table 5
Repeated Measures of ANOVA Test of Within-Group Effects of ARMS
SS
df
F
p
______________________________________________________________________________
Time

13.87

1

2.18

.15

Time x Intervention
4.67
2
2.33
.70
_____________________________________________________________________________

Figure 8
Estimated Marginal Means of ARMS
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Hypothesis 2.1: Breast cancer survivors provided with cancer survival skills training
plus medication adherence skills training in a psychoeducational group setting will report
significantly better self-efficacy in medication adherence compared to survivors provided with
medication adherence skills training only or those receiving no intervention at 4-6 month followup.
Hypothesis 2.2: Breast cancer survivors provided with medication adherence skills
training only in a psychoeducational group setting will report significantly better self-efficacy in
medication adherence compared to survivors receiving no intervention at 4-6 month follow-up.
Results. Hypotheses 2.1 and 2.2 were tested using the SEAMS questionnaire as the
repeated measure dependent variable. Total score for the SEAMS questionnaire was used in the
data analysis. Reapeated measures ANOVA showed that there was no statistically significant
difference within groups. Consequently, no analysis between groups was warranted. Results are
reported in Table 6 and Figure 9.
Table 6
Repeated Measures of ANOVA Test of Within-Group Effects of SEAMS
SS
df
F
p
______________________________________________________________________________
Time
5.75
1
.22
.64
Time x Intervention

18.19

2

.34

89

.71

Figure 9
Estimated Marginal Means of SEAMS
Post-hoc analyses
Health literacy
The questions of the 3 question health literacy questionnaire were analyzed individually
and collectively using repeated measures ANOVA. There was no statistically significant
outcome within any of the three groups for each of the questions analyzed or for the composite
score (Qtot). Consequently, no analysis between groups was warranted. Table 7 and Figures 1013 summarize the findings.
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Table 7
Repeated Measures of ANOVA Test of Within-Group Effects of Health Literacy Questionnaire
SS
df
F
p
______________________________________________________________________________
Q1 Time
.96
1
1.92
.17
Time x Intervention
Q2 Time
Time x Intervention
Q3 Time
Time x Intervention
Total Time
Time x Intervention

.09

2

.09

.91

.05

1

.05

.82

1.39

2

.76

.47

1.41

1

1.49

.23

1.19

2

.63

.54

3.80

1

1.71

.20

4.23

2

.95

.39

Q1: How often do you have problems learning about your medical condition because of
difficulty understanding written informaion?
Q2: How often do you have someone help you read hospital materials?
Q3: How confident are you filling out medical forms by yourself?
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Figure 10
Question 1
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Figure 11
Question 2

Figure 12
Question 3
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Figure 13
3 Question Composite

Analysis of treatment groups. Treatment groups 1 and 2 (CSS + MTM) were treated as
one group to determine if any type of intervention had an effect on medication adherence and
self-efficacy. Analyses were conducted using independent samples t-test. The changes in pre and
post test scores for medication adherence and self-efficacy were computed and compared by
treatment and control groups. There was a no significant change found between the two groups
for either medication adherence or self-efficacy. Tables 8 and 9 summarize the findings.
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Table 8
Comparison of change in ARMS scores in treatment group and control
N

Mean

SD

p

Treatment (CSS+MTM)

42

.45

3.74

.61

Control

19

1.05

3.08

Table 9.
Comparison of change in SEAMS scores in treatment group and control
N

Mean

SD

p

Treatment (CSS+MTM)

42

-1.00

8.05

.42

Control

19

.63

4.82

Analysis of medication adherence, self-efficacy, and demographic variables.
Bivariate correlations were used to analyze the effect of demographic variables that may affect
either medication adherence or self-efficacy post intervention. The variables tested were 1) age
of participant 2) age at diagnosis, 3) number of children, 4) number of people living in
household, 5) years of school completed and 6) number of medications. The dependent variables
tested were the ARMS composite posttest and the SEAMS composite posttest. Results showed a
significant, weak negative correlation between medication adherence and age (r = -.25), and a
significant, weak relationship between medication adherence and number of people living in
household (r=.26). There was a significant, positive correlation between age and self-efficacy
(r=.34), and age at diagnosis and self-efficacy (r=.29). In addition, there was a weak, negative
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relationship between number of people in household and self-efficacy (r=.26). Tables 10 and 11
summarize the findings.
Table 10
Bivariate Correlations of Medication Adherence and Demographic Variables
r

p

Age of participant

-.25

.05

Age at diagnosis

-.24

.07

Number of Children

-.12

.36

.26

.04

Number of medications

-.01

.96

Number years of school completed

-.01

.96

Number of people living in household

Table 11
Bivariate Correlations of Self-Efficacy and Demographic Variables
r

p

Age of participant

.34

.01

Age at diagnosis

.29

Number of Children

.01

.95

Number of people living in household

-.26

.04

Number of medications

.17

.25

Number years of school completed

.04

.76

.

.03

Variables showing a significant correlation were analyzed individually using regression
analysis. Regression analysis indicated a significant, negative relationship between age and
medication adherence (B=-.11, p=.05) and a positive relationship between number of people
living in household and medication adherence (B=.64, p=.04). There was a significant positive
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relationship between age and self-efficacy (B=.20, p=.01), age at diagnosis and self-efficacy
(B=.17, p=.03), and a significant negative relationship between number of people living in
household and self-efficacy (B=-.88, p=.04). Tables 12 and 13 summarize the findings.
Table 12
Regression Analysis: Medication Adherence, Age, and Number of People Living in Household
F

R

R2

B

p

Age

3.96

.25

.06

-.11

.05

Number of people living in household

4.19

.26

.07

.64

.04

Table 13
Regression Analysis: Self-Efficacy, Age, Age at Diagnosis, and Number of People Living in
Household
F

R

R2

B

Age

7.45

.34

.11

.20

.01

Age at diagnosis

4.91

.29

.08

.17

.03

Number of people living in household

4.33

.26

.07

-.88

.04

p

Analyses of post workshop surveys. Descriptive analyses were conducted comparing
the means of the composite scores of the post workshop surveys. The range for composite scores
for all surveys was 5-20. Table 14 summarizes the mean scores of the individual questions asked
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on the MTM post workshop survey. Results indicated favorable responses for all four questions.
Table 15 provides mean response scores for question four (“Has this training session been
helpful to you?”) of all seven post workshop surveys. Results are summarized in Table 14.
Scores indicate favorable responses for all workshops.
Table 14
Descriptive Summary of MTM Post Workshop Survey
N Min Max

Mean

SD

Has your confidence about your ability to gain
information about your medications increased?

40

3

5

4.70

.61

40

3

5

4.85

.43

increased?

40

3

5

4.55

.75

Has this training session been helpful to you?

40

4

5

4.95

.22

Total

40

15

20

19.05 1.47

Has your understanding of the importance of
following medication directions increased?
Has your confidence in taking your medications

Table 15
Descriptive Summary of Post Workshop Surveys Question Four Scores
N

Mean

SD

Session 1: Communication

15

4.87

.35

Session 2: Finding Information

14

5.00

.00

Session 3: Making Decisions

16

4.94

.25

Session 4: Problem Solving

8

5.00

.00

Session 5: Negotiating

7

4.86

.38

Session 6: Standing up for your Rights

15

5.00

.00

Session 7: Medication Adherence

40

4.95

.22
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Chapter 8
Discussion
Analysis of Findings.
Testing of Hypotheses. Results of analyses testing hypotheses revealed that the null
hypotheses of objective one and objective two of the study could not be rejected. The study
could not confirm that cancer skills training plus medication adherence testing nor medication
adherence skills training alone had a positive effect on medication adherence or self-efficacy.
Even so, results support previous research that higher self-efficacy is associated with higher
medication adherence (Colbert et al., 2012). Ad hoc testing of health literacy did not show a
statistically significant association between health literacy and medication adherence or selfefficacy.
It needs to be noted that baseline scores for both the ARMS and the SEAMS were high,
which may have influenced the lack of significance. High pretest scores indicate initially high
medication adherence and self-efficacy, which makes significant improvement difficult to attain.
Possible explanations for high pretest scores are discussed in the limitations section of this
chapter.
Ad hoc Testing
Additional ad hoc testing using regression analysis indicated significant relationships
between medication adherence, age, and number of people living in household, and self-efficacy,
age, age at diagnosis, and number of people living in household. These findings support the
theory that women, particularly African American women, are often the primary caretakers of
the family system (Abel & Subramanian, 2008; Staat & Segatore, 2005). They are also members
of a population that lives in a collective environment where perceived personal risk is assessed
99

within the context of group risk (Ashing-Giwa, 1999). Having the added burden of taking care of
themselves and additional family members may cause the patient to feel overwhelmed, distressed
and disempowered (Darby, Davis, Likes & Bell, 2009; Davis, Darby, Likes & Bell, 2009; Davis,
Emerson, & Husaini, 2005; Hamilton, et al., 2010; Mosavel and Sanders, 2010, Sharf, 1997;
Shields, 1995).
Competence and self-determination must occur in an environment conducive to providing
autonomy support while fulfilling the need for relatedness and connectedness (Markland et al.,
2005). Self-efficacy is an essential component of assessing medication adherence (Risser,
Jacobsen & Kripilani, 2007). Having additional members of the household may directly
influence both the internal and external locus of control of the breast cancer survivor (Ajzen,
2002, Rosenstock, Strecher & Becker, 1988, Strecher, DeVellis, Becker & Rosenstock, 1986;
Wallston & Wallston, 1984).
Post workshop survey. Analysis of the post workshop surveys revealed that means of the
composite scores ranged from 18.33 to 19.33, indicating a positive response to the skills
workshops. This corroborates research that discussion of medication usage is helpful (DiIorio et
al., 2003). It also supports the literature regarding the importance of providing health information
in a format that is easily accessible and communicated in an understandable fashion (Atkins &
Fallowfield, 2006; Barber, 2002; Chew, Bradley, & Boyko, 2004; Ransom, Jacobsen et al., 2005;
Davey, 2010; Jeppesen, Coyle & Misser, 2009; Royak-Schaler, 2008).
Limitations
Recruitment and Randomization. The participants of the study were randomized, and
analysis of demographic data reflected this. However, methods of recruitment may have skewed
the sample.
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Eligibility Criteria. Participants were eligible only within one year of treatment for
breast cancer. This may have also skewed the data since the participants had recently been under
the care of health care professionals for an extended period of time.
Sample. Recruitment for the study was challenging due to the narrow window of
eligibility. This led to small sample size and low numbers in each study group. Post hoc analysis
revealed that the low sample size did not allow for adequate power for the study and affected the
robustness of the study. Furthermore, the majority of the participants were breast cancer
survivors who were members of breast cancer support groups that provided social support,
education and access to resources. The relationship between the participants and their health care
providers may have been a factor in the high test scores (Pratt et al., 2001; Phatak & Thomas,
2006). The mean number of medications (3.80) was less than that reported by Puts et al. (2009).
The pretest scores reflected an existing grasp of proper medication adherence and self-efficacy in
taking medications as well as functional health literacy.
Variability of workshops. Due to slow recruitment, multiple workshops were required
over a one and one-half year period. Even though every effort was made to ensure continuity of
the workshops, variability in presenters, locations and time may have had an impact on the study.
Implications for Future Research
Although there were no significant findings with respect to medication adherence and
self-efficacy, additional studies with larger sample sizes, expanded eligibility criteria and
alternative measures of health literacy and medication adherence are suggested. Additional
measures (quality of life, depression, cancer skills) that were administered for future data
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analysis may allow for further investigation with medication adherence, self-efficacy and health
literacy.
Many studies report that distress related to a woman’s physical and psychological
adjustment to breast cancer can be detrimental to decision making, treatment compliance and
outcomes (Allen et al., 2002; Blake-Mortimer, Gore-Felton, Kimerling, Turner-Cobb & Spiegel,
1999; Ganz et al., 1993; Ganz, et al., 2004; Graves, 2003; Heim, Valach & Schaffner, 1997;
McCaul et al., 1999; Patrick-Miller, Broccoli, Much & Levine, 2004; Schnoll, Harlow, Stolbach
& Brandt, 1998; Stanton, 2006; Stanton et al., 2000). Further research into the effect of distress
on medication adherence and self-efficacy warrants consideration.
In addition to the research proposed above, exploration of the effect of empowerment on
health literacy, medication adherence and self-efficacy is indicated. Empowerment promotes
self-efficacy, which is the ability to make informed decisions (Davis, Darby, Likes & Bell, 2009;
Sharf, 1997; Shields, 1995), and allows individuals to manage their lives (Clark & Stovall, 1996;
Gray, Doan & Churchm 1991; Henderson & Thomas, 1987). Emphasis on the tenet that patients
should be engaged in their health care (Clark & Stovall, 1996; Clark & Stovall, 2004; Stecher,
DeVillis, Becker & Rowenstack, 1986; Walsh-Burke & Marcusenn, 1999) would provide
valuable information in the areas that were explored in this study. Empowering breast cancer
survivors and their families to gain access to services and support throughout treatment and
recovery is crucial in improving quality of life for breast cancer patients and their family systems
(Freeman. 2006; Hiatt et al., 2003; Till, 2001).
Finally, the most startling find of this study for this researcher was the lack of specific
measure for pharmacy literacy. The most common measures that exist for health literacy have
been validated for measurement of health literacy on a global level, and include the ability to
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read and understand health information, appointment dates, insurance information and nutrition
labels. Although there has been some preliminary activity (Jacobson et al. 2007), the lack of
measurement of knowledge of prescription labels, medication information, side effects, drug
interactions and information provided by health care providers about medications was alarming
at best for this researcher. This area of research is rich with possibilities for collaboration
between the professions of social work and pharmacy to explore this particular knowledge gap.
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Chapter 9
Conclusions
“It’s not about the destination…it’s about the journey.” I have said and believed this
saying for quite some time. I have even offered versions of this saying to my children and fellow
breast cancer survivors throughout my adult life. During this dissertation process, I have had to
modify and cling to this adage. Although not a young student, I approached the doctoral program
and dissertation like a wide-eyed, idealistic neophyte, not necessarily trying to change the world
with one study, but at least prove that my beliefs were obvious truths. These truths were that
health literacy has an impact on medication adherence and that providing skills training to breast
cancer survivors would not only improve medication adherence and self-efficacy but would
impact health literacy as well.
The opportunity to participate in a randomized controlled study for my dissertation is
something of which most doctoral students only dream. Having the good fortune to receive the
Doctoral Training Grant from the American Cancer Society afforded me the opportunity to
expand my study into an experimental design. This has been an incredible learning experience
for me, and, although I envisioned (and I write this tongue in cheek) a perfect, seamless study
with extraordinary, groundbreaking results worthy of international renown, I can truly say that I
have learned more by the lack of results to report.
“It’s not about the results…it’s about the process.” How true. If I had been able to reject
the null on all my hypotheses and have a “perfect” study I may never have delved into secondary
data analysis and learned how to search for the most miniscule bit of information. Lack of
“perfection” has helped to make me a better researcher. Lack of “perfection” has helped me to
realize how little I know and how many opportunities for growth lie ahead.
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While in the master’s program I participated in a pilot program for Medication Therapy
Management. Two years later I co-authored an article on Medication Therapy Management that
was written for social workers (Rust & Davis, 2011). This particular article was designed to
introduce the process of providing extensive medication counseling to patients and opportunities
for social work in this process. Through this dissertation process, I feel even more strongly that
opportunities abound for social workers to be viable participants in the collaborative health care
process when it comes to medication adherence and health literacy – especially within oncology
social work.
One important example of this collaboration is a recent program developed through the
combined efforts of the Oncology Nursing Society, National Coalition for Cancer Survivorship,
National Association of Social Workers and the Association of Oncology Social Work. A oneday multidisciplinary workshop was provided for teams of oncology social workers, nurses and
pharmacists to be trained as trainers for workshops in oral chemotherapy medication adherence
(NCCS, NASW, ONS & AOSW, 2011). It is encouraging to see and experience collaborations
such as this.
Working on this study within a collaborative framework between social work and
pharmacy provided the opportunity to experience firsthand the process of obtaining outcome
measures to provide evidence based data. Although the outcomes were not anticipated, the
process ignited a desire to continue down the path of investigating the role of pharmacy literacy
in medication adherence, particularly with breast cancer survivors.
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ARMS Questionnaire

ADHERENCE TO REFILLS AND MEDICATIONS SCALE (ARMS)
I will now ask you how often you actually miss taking your medicines and how often you can’t
make it to your medical appointments. There are no right or wrong answers. For each question,
please answer “none of the time,” “some of the time,” “most of the time,” or “all of the time.”
Most

All

How often do you forget to take your medicine?

None
1

2

3

4

How often do you decide not to take your medicine?

1

2

3

4

How often do you forget to get prescriptions filled?

1

2

3

4

How often do you run out of medicine?

1

2

3

4

How often do you skip a dose of your medicine before
you go to the doctor?

1

2

3

4

How often do you miss taking your medicine when
you feel better?

1

2

3

4

1

2

3

4

1

2

3

4

How often do you miss taking your medicine when
you feel sick?
How often do you miss taking your medicine when you
are careless?

Some

How often do you change the dose of your medicines
to suit your needs (like when you take more or less pills
than you’re supposed to)?

1

2

3

4

How often do you forget to take your medicine when you are
supposed to take it more than once a day?

1

2

3

4

How often do you put off refilling your medicines because
they cost too much money?

1

2

3

4

1

2

3

4

How often do you plan ahead and refill your medicine
before they run out?
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SEAMS Questionnaire

SELF-EFFICACY ASSESSMENT
A lot of people have trouble taking their medicines like their doctor prescribes. Sometimes, people also can’t make it to their doctor’s
appointments. I would like to ask you your opinion about taking your medicines and keeping your appointments. I want to learn what you think
you can do under several different conditions, not actually what you do. For each situation, let me know whether you are “not at all confident,”
“somewhat confident,” or “very confident.”

How confident are you that you can take your medicines correctly……..
Not
confident

Somewhat

Very

confident

confident

12. When you take several different medicines each day.

1

2

3

13. When you take medicines more than once a day.

1

2

3

14. When you are away from home.

1

2

3

15. When you have a busy day planned.

1

2

3

16. When they cause some side effects.

1

2

3

17. When no one reminds you to take the medicine.

1

2

3

18. When the schedule to take the medicine is not
convenient.

1

2

3

19. When your normal routine gets messed up.

1

2

3

20. When you are not sure how to take the medicine.

1

2

3

21. When you are not sure what time of the day to take
your medicine.

1

2

3

22. When you are feeling sick (you know, like having
a cold or the flu).

1

2

3

23. When you get a refill of your old medicines and
some of the pills look different than usual.

1

2

3

24. When a doctor changes your medicines.

1

2

3
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Three Question Health Literacy Assessment

1.

How often do you have problems learning about your medical condition because of
difficulty understanding written information?
always

2.

sometimes

occasionally

never

How often do you have someone help you read hospital materials?
always

3.

often

often

sometimes

occasionally

never

How confident are you filling out medical forms by yourself?
always

often

sometimes

149

occasionally

never

Medication Adherence Skills Workshop Evaluation Form
Please circle the response that best represents what you have gained as a result of this
program:
1. Has your confidence about your ability to gain information about your medications
increased?
1
not at all

2
a little

3
somewhat

4
quite a bit

5
a great deal

2. Has your understanding of the importance of following medication directions increased?
1
not at all

2
a little

3
somewhat

4
quite a bit

5
a great deal

3. Has your confidence in taking your medications increased?
1
not at all

2
a little

3
somewhat

4
quite a bit

5
a great deal

4
quite a bit

5
a great deal

4. Has this training session been helpful to you?
1
not at all

2
a little

3
somewhat

Additional Comments: Please tell us anything else you would like about what you thought
of this training session or how you might use what you learned.
_____________________________________________________________________________
_____________________________________________________________________________
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IRB Forms
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